{"AllianceGenome": "7765", "HGNC": "7765", "MIM": "613113", "_id": "4763", "_version": 1, "accession": {"genomic": ["AB195812.1", "AB195813.1", "AC004222.1", "AC079915.7", "AC134669.4", "AC135724.9", "AC138207.3", "AC139072.3", "AC277945.1", "AH000834.2", "AH005101.2", "AY563167.1", "AY796305.1", "CH471147.2", "CP068261.2", "KX894288.1", "KX894291.1", "KX894292.1", "KX894293.1", "KX894294.1", "KX894295.1", "KX894296.1", "KX894297.1", "L05367.1", "NC_000017.11", "NC_060941.1", "NG_009018.1", "NW_025791803.1", "S57959.1", "S57966.1", "S61428.1", "S61433.1", "X73654.1", "X76888.1", "Y07853.1"], "protein": ["AAA18483.1", "AAA59921.1", "AAA59922.1", "AAA59923.1", "AAA59924.1", "AAA59925.1", "AAA59928.1", "AAA74897.1", "AAB24636.1", "AAB26693.1", "AAB26694.1", "AAB48373.1", "AAB48374.1", "AAB48375.1", "AAB48376.1", "AAB48377.1", "AAB48378.1", "AAB48379.1", "AAB48380.1", "AAB59558.1", "AAD13890.1", "AAD14922.1", "AAS67035.1", "AAV50004.1", "APC25502.1", "APC25505.1", "APC25506.1", "APC25507.1", "APC25508.1", "APC25509.1", "APC25510.1", "APC25511.1", "BAA01371.1", "BAA02150.1", "BAA07669.1", "BAD92573.1", "BAD98998.1", "BAD98999.1", "BAF82625.1", "BAG63383.1", "BAG63453.1", "CAA52021.1", "CAA69179.1", "CAD97858.1", "EAW80267.1", "EAW80268.1", "EAW80269.1", "EAW80270.1", "EAW80271.1", "EAW80272.1", "EAW80273.1", "EAW80274.1", "EAW80275.1", "NP_000258.1", "NP_001035957.1", "NP_001121619.1", "P21359.2"], "rna": ["AB209336.1", "AF055023.1", "AF086346.1", "AK024873.1", "AK026658.1", "AK289936.1", "AK301970.1", "AK302063.1", "BC144643.1", "BP271334.1", "BX391799.2", "BX537850.1", "CN415204.1", "D10490.1", "D12625.1", "D42072.1", "DA299151.1", "DB094344.1", "M38106.1", "M38107.1", "M60496.1", "M60915.1", "M61213.1", "M82814.1", "M89914.1", "NM_000267.3", "NM_001042492.3", "NM_001128147.3", "S51751.1"], "translation": [{"protein": "AAA59923.1", "rna": "M61213.1"}, {"protein": "AAA59928.1", "rna": "M60496.1"}, {"protein": "AAA59925.1", "rna": "M89914.1"}, {"protein": "BAA01371.1", "rna": "D10490.1"}, {"protein": "AAA59921.1", "rna": "M60915.1"}, {"protein": "NP_000258.1", "rna": "NM_000267.3"}, {"protein": "AAA59924.1", "rna": "M82814.1"}, {"protein": "NP_001121619.1", "rna": "NM_001128147.3"}, {"protein": "BAD92573.1", "rna": "AB209336.1"}, {"protein": "BAG63453.1", "rna": "AK302063.1"}, {"protein": "BAA02150.1", "rna": "D12625.1"}, {"protein": "BAG63383.1", "rna": "AK301970.1"}, {"protein": "BAA07669.1", "rna": "D42072.1"}, {"protein": "CAD97858.1", "rna": "BX537850.1"}, {"protein": "AAA59922.1", "rna": "M60915.1"}, {"protein": "AAB24636.1", "rna": "S51751.1"}, {"protein": "BAF82625.1", "rna": "AK289936.1"}, {"protein": "AAB59558.1", "rna": "M38107.1"}, {"protein": "AAA74897.1", "rna": "M38106.1"}, {"protein": "NP_001035957.1", "rna": "NM_001042492.3"}]}, "alias": ["NFNS", "VRNF", "WSS"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2019-03-05T17:00:00.000Z", "disease_label": "neurofibromatosis type 1", "gcep": "General Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0018975", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_367a3958-ce81-47fa-a505-a451ca67aab5-2019-03-05T170000.000Z", "sop": "SOP7"}, {"classification": "no known disease relationship", "classification_date": "2017-02-22T00:00:00", "disease_label": "familial ovarian cancer", "gcep": "Breast/Ovarian Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0016248", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10082", "sop": "SOP4"}]}, "ensembl": {"gene": "ENSG00000196712", "protein": ["ENSP00000348498", "ENSP00000351015", "ENSP00000389907", "ENSP00000412921", "ENSP00000462157", "ENSP00000462408", "ENSP00000462700", "ENSP00000463682", "ENSP00000463819", "ENSP00000464678", "ENSP00000464702", "ENSP00000465138", "ENSP00000467080", "ENSP00000491431", "ENSP00000491589", "ENSP00000492721", "ENSP00000508715", "ENSP00000509682", "ENSP00000509994", "ENSP00000510031", "ENSP00000510595", "ENSP00000510673", "ENSP00000512431", "ENSP00000512432", "ENSP00000512433"], "transcript": ["ENST00000356175", "ENST00000358273", "ENST00000422121", "ENST00000431387", "ENST00000456735", "ENST00000466819", "ENST00000468273", "ENST00000471572", "ENST00000479536", "ENST00000479614", "ENST00000487476", "ENST00000488981", "ENST00000489712", "ENST00000490416", "ENST00000493220", "ENST00000495910", "ENST00000498569", "ENST00000577967", "ENST00000579081", "ENST00000581113", "ENST00000581790", "ENST00000582892", "ENST00000584328", "ENST00000684826", "ENST00000684998", "ENST00000686189", "ENST00000687027", "ENST00000687863", "ENST00000688507", "ENST00000689464", "ENST00000691014", "ENST00000691649", "ENST00000692326", "ENST00000693210", "ENST00000693617", "ENST00000696138", "ENST00000696139", "ENST00000696140", "ENST00000696141"], "translation": [{"protein": "ENSP00000491589", "rna": "ENST00000487476"}, {"protein": "ENSP00000348498", "rna": "ENST00000356175"}, {"protein": "ENSP00000512431", "rna": "ENST00000696138"}, {"protein": "ENSP00000412921", "rna": "ENST00000431387"}, {"protein": "ENSP00000351015", "rna": "ENST00000358273"}, {"protein": "ENSP00000510595", "rna": "ENST00000691014"}, {"protein": "ENSP00000462408", "rna": "ENST00000579081"}, {"protein": "ENSP00000463682", "rna": "ENST00000495910"}, {"protein": "ENSP00000491431", "rna": "ENST00000490416"}, {"protein": "ENSP00000509682", "rna": "ENST00000686189"}, {"protein": "ENSP00000389907", "rna": "ENST00000456735"}, {"protein": "ENSP00000512432", "rna": "ENST00000696139"}, {"protein": "ENSP00000463819", "rna": "ENST00000466819"}, {"protein": "ENSP00000462157", "rna": "ENST00000479614"}, {"protein": "ENSP00000512433", "rna": "ENST00000696141"}, {"protein": "ENSP00000492721", "rna": "ENST00000581113"}, {"protein": "ENSP00000508715", "rna": "ENST00000687027"}, {"protein": "ENSP00000510031", "rna": "ENST00000693617"}, {"protein": "ENSP00000509994", "rna": "ENST00000684826"}, {"protein": "ENSP00000467080", "rna": "ENST00000479536"}, {"protein": "ENSP00000462700", "rna": "ENST00000581790"}, {"protein": "ENSP00000464678", "rna": "ENST00000471572"}, {"protein": "ENSP00000510673", "rna": "ENST00000689464"}, {"protein": "ENSP00000464702", "rna": "ENST00000468273"}, {"protein": "ENSP00000465138", "rna": "ENST00000422121"}], "type_of_gene": "protein_coding"}, "entrezgene": "4763", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 104.937464459, "exp_mis": 850.88085934, "exp_syn": 337.738994516, "lof_z": 8.7936108160201, "mis_z": 6.21894243526362, "mu_lof": 7.38666979517e-06, "mu_mis": 7.54410314535e-05, "mu_syn": 2.88476343526e-05, "n_lof": 14.0, "n_mis": 480.0, "n_syn": 333.0, "p_li": 0.999999845570262, "p_null": 1.06071944201526e-27, "p_rec": 1.54429738043446e-07, "syn_z": 0.159862115826485}, "bp": 8520, "cds_end": 29701173, "cds_start": 29422327, "n_exons": 58, "nonpsych": {"exp_lof": 93.8323063756, "exp_mis": 768.983082465, "exp_syn": 304.540170873, "lof_z": 8.3979933654054, "mis_z": 6.3111957406008, "mu_lof": 7.38666979517e-06, "mu_mis": 7.54410314535e-05, "mu_syn": 2.88476343526e-05, "n_lof": 11.0, "n_mis": 422.0, "n_syn": 299.0, "p_li": 0.999999939046812, "p_null": 1.62208325797896e-26, "p_rec": 6.0953188230174e-08, "syn_z": 0.199878746850153}, "nontcga": {"exp_lof": 96.430743996, "exp_mis": 782.698719555, "exp_syn": 310.608176392, "lof_z": 8.5819835482116, "mis_z": 6.40547540935147, "mu_lof": 7.38666979517e-06, "mu_mis": 7.54410314535e-05, "mu_syn": 2.88476343526e-05, "n_lof": 11.0, "n_mis": 423.0, "n_syn": 306.0, "p_li": 0.999999974638712, "p_null": 1.56820063718511e-27, "p_rec": 2.53612883352878e-08, "syn_z": 0.165556847539852}, "transcript": "ENST00000358273.4"}, "exons": [{"cdsend": 31374155, "cdsstart": 31095309, "chr": "17", "position": [[31094926, 31095369], [31155982, 31156126], [31159009, 31159093], [31163185, 31163376], [31169890, 31169997], [31181421, 31181489], [31181709, 31181785], [31182507, 31182665], [31200421, 31200595], [31201036, 31201159], [31201410, 31201485], [31206239, 31206371], [31214450, 31214585], [31219004, 31219118], [31221849, 31221929], [31223443, 31223567], [31225094, 31225250], [31226434, 31226684], [31227217, 31227291], [31227522, 31227606], [31229024, 31229465], [31229834, 31229974], [31230259, 31230382], [31230841, 31230925], [31232072, 31232189], [31232699, 31232881], [31233001, 31233213], [31235610, 31235772], [31235917, 31236021], [31248983, 31249119], [31258343, 31258502], [31259031, 31259129], [31260368, 31260515], [31261710, 31261857], [31265228, 31265339], [31325819, 31326252], [31327498, 31327839], [31330295, 31330498], [31334837, 31335031], [31336332, 31336473], [31336634, 31336914], [31337367, 31337582], [31337818, 31337880], [31338024, 31338139], [31338703, 31338805], [31340504, 31340645], [31343008, 31343135], [31349119, 31349251], [31350182, 31350318], [31352256, 31352414], [31356459, 31356582], [31356959, 31357090], [31357268, 31357369], [31358479, 31358622], [31358968, 31359015], [31360486, 31360703], [31374012, 31377677]], "strand": 1, "transcript": "NM_000267", "txend": 31377677, "txstart": 31094926}, {"cdsend": 31374155, "cdsstart": 31095309, "chr": "17", "position": [[31094976, 31095369], [31155982, 31156126], [31159009, 31159093], [31163185, 31163376], [31169890, 31169997], [31181421, 31181489], [31181709, 31181785], [31182507, 31182665], [31200421, 31200595], [31201036, 31201159], [31201410, 31201485], [31206239, 31206371], [31214450, 31214585], [31219004, 31219118], [31221849, 31221929], [31223443, 31223567], [31225094, 31225250], [31226434, 31226684], [31227217, 31227291], [31227522, 31227606], [31229024, 31229465], [31229834, 31229974], [31230259, 31230382], [31230841, 31230925], [31232072, 31232189], [31232699, 31232881], [31233001, 31233213], [31235610, 31235772], [31235917, 31236021], [31248983, 31249119], [31252937, 31253000], [31258343, 31258502], [31259031, 31259129], [31260368, 31260515], [31261710, 31261857], [31265228, 31265339], [31325819, 31326252], [31327498, 31327839], [31330295, 31330498], [31334837, 31335031], [31336332, 31336473], [31336634, 31336914], [31337367, 31337582], [31337818, 31337880], [31338024, 31338139], [31338703, 31338805], [31340504, 31340645], [31343008, 31343135], [31349119, 31349251], [31350182, 31350318], [31352256, 31352414], [31356459, 31356582], [31356959, 31357090], [31357268, 31357369], [31358479, 31358622], [31358968, 31359015], [31360486, 31360703], [31374012, 31377675]], "strand": 1, "transcript": "NM_001042492", "txend": 31377675, "txstart": 31094976}, {"cdsend": 31221990, "cdsstart": 31095309, "chr": "17", "position": [[31094976, 31095369], [31155982, 31156126], [31159009, 31159093], [31163185, 31163376], [31169890, 31169997], [31181421, 31181489], [31181709, 31181785], [31182507, 31182665], [31200421, 31200595], [31201036, 31201159], [31201410, 31201485], [31206239, 31206371], [31214450, 31214585], [31219004, 31219118], [31221849, 31222764]], "strand": 1, "transcript": "NM_001128147", "txend": 31222764, "txstart": 31094976}], "exons_hg19": [{"cdsend": 29701173, "cdsstart": 29422327, "chr": "17", "position": [[29421944, 29422387], [29483000, 29483144], [29486027, 29486111], [29490203, 29490394], [29496908, 29497015], [29508439, 29508507], [29508727, 29508803], [29509525, 29509683], [29527439, 29527613], [29528054, 29528177], [29528428, 29528503], [29533257, 29533389], [29541468, 29541603], [29546022, 29546136], [29548867, 29548947], [29550461, 29550585], [29552112, 29552268], [29553452, 29553702], [29554235, 29554309], [29554540, 29554624], [29556042, 29556483], [29556852, 29556992], [29557277, 29557400], [29557859, 29557943], [29559090, 29559207], [29559717, 29559899], [29560019, 29560231], [29562628, 29562790], [29562935, 29563039], [29576001, 29576137], [29585361, 29585520], [29586049, 29586147], [29587386, 29587533], [29588728, 29588875], [29592246, 29592357], [29652837, 29653270], [29654516, 29654857], [29657313, 29657516], [29661855, 29662049], [29663350, 29663491], [29663652, 29663932], [29664385, 29664600], [29664836, 29664898], [29665042, 29665157], [29665721, 29665823], [29667522, 29667663], [29670026, 29670153], [29676137, 29676269], [29677200, 29677336], [29679274, 29679432], [29683477, 29683600], [29683977, 29684108], [29684286, 29684387], [29685497, 29685640], [29685986, 29686033], [29687504, 29687721], [29701030, 29704695]], "strand": 1, "transcript": "NM_000267", "txend": 29704695, "txstart": 29421944}, {"cdsend": 29701173, "cdsstart": 29422327, "chr": "17", "position": [[29421994, 29422387], [29483000, 29483144], [29486027, 29486111], [29490203, 29490394], [29496908, 29497015], [29508439, 29508507], [29508727, 29508803], [29509525, 29509683], [29527439, 29527613], [29528054, 29528177], [29528428, 29528503], [29533257, 29533389], [29541468, 29541603], [29546022, 29546136], [29548867, 29548947], [29550461, 29550585], [29552112, 29552268], [29553452, 29553702], [29554235, 29554309], [29554540, 29554624], [29556042, 29556483], [29556852, 29556992], [29557277, 29557400], [29557859, 29557943], [29559090, 29559207], [29559717, 29559899], [29560019, 29560231], [29562628, 29562790], [29562935, 29563039], [29576001, 29576137], [29579955, 29580018], [29585361, 29585520], [29586049, 29586147], [29587386, 29587533], [29588728, 29588875], [29592246, 29592357], [29652837, 29653270], [29654516, 29654857], [29657313, 29657516], [29661855, 29662049], [29663350, 29663491], [29663652, 29663932], [29664385, 29664600], [29664836, 29664898], [29665042, 29665157], [29665721, 29665823], [29667522, 29667663], [29670026, 29670153], [29676137, 29676269], [29677200, 29677336], [29679274, 29679432], [29683477, 29683600], [29683977, 29684108], [29684286, 29684387], [29685497, 29685640], [29685986, 29686033], [29687504, 29687721], [29701030, 29704693]], "strand": 1, "transcript": "NM_001042492", "txend": 29704693, "txstart": 29421994}, {"cdsend": 29549008, "cdsstart": 29422327, "chr": "17", "position": [[29421994, 29422387], [29483000, 29483144], [29486027, 29486111], [29490203, 29490394], [29496908, 29497015], [29508439, 29508507], [29508727, 29508803], [29509525, 29509683], [29527439, 29527613], [29528054, 29528177], [29528428, 29528503], [29533257, 29533389], [29541468, 29541603], [29546022, 29546136], [29548867, 29549782]], "strand": 1, "transcript": "NM_001128147", "txend": 29549782, "txstart": 29421994}], "generif": [{"pubmed": 10625171, "text": "Meta-analysis and HuGE review of gene-disease association and genetic testing. (HuGE Navigator)"}, {"pubmed": 11704931, "text": "spinal neurofibromatosis without cafe-au-lait macules in two families with null mutations of the NF1 gene"}, {"pubmed": 11727199, "text": "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme"}, {"pubmed": 11727265, "text": "mutation analysis of the NF1 gene in osteofibrous dysplasia"}, {"pubmed": 11748857, "text": "Combination of analyses of loss of heterozygosity, southern blotting and southern blot densitometry can be used as a powerful method to detect large deletions, especially when family record is not available or the patient is a sporadic case."}, {"pubmed": 11751683, "text": "Heterozygous astrocytes have decreased attachment, delayed actin cytoskeleton re-organization during cell spreading, and increased motility."}, {"pubmed": 11754043, "text": "Genotype analysis indicated families 7610 and 7473 bear deletions."}, {"pubmed": 11857752, "text": "No correlation has been found between type, location or size of NF1 mutations and size or location of plexiform neurofibromas (PNFs), suggesting that many types of NF1 mutations may lead to development of PNFs."}, {"pubmed": 11896214, "text": "This study demonstrated that NF1 mRNA belongs to a rare group of mRNAs that are not targeted to free polysomes or ribosomes of the rough endoplasmic reticulum."}, {"pubmed": 11934389, "text": "linkage disequilibrium and founder effect analysis of the NF1 gene in French Canadians from the Quebec population"}, {"pubmed": 12073021, "text": "report novel aberrant NF1 splicing, which is not random and affects only specific parts of the transcript across its length"}, {"pubmed": 12077339, "text": "Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation."}, {"pubmed": 12095621, "text": "Various new NF1 splice variants was described. Furhter insight into the significance of some of these variants is provided by accurate quantification of variant transcript levels in different human tissues."}, {"pubmed": 12152785, "text": "Differential NF1 patterns by interphase cytogenetics in malignant peripheral nerve sheath tumor and morphologically similar spindle cell neoplasms."}, {"pubmed": 12191989, "text": "the motor protein kinesin-1 links this protein and merlin in a common cellular pathway of neurofibromatosis"}, {"pubmed": 12199909, "text": "NF1 tumor suppressor may function in the regulation of epidermal histogenesis via controlling the organization of the keratin cytoskeleton during the assembly of desmosomes and hemidesmosomes."}, {"pubmed": 12368469, "text": "In the cells haploinsufficient for NF1 we found an altered signal-to-noise ratio detectable as increased variation in dendrite formation."}, {"pubmed": 12387455, "text": "probably does not have a role as tumor suppressor in sporadic pilocytic astrocytomas"}, {"pubmed": 12522551, "text": "nf1 gene is a mutational target in a mismatch repair-deficient cell and its inactivation is an important step of the malignant progression of MMR-deficient cells"}, {"pubmed": 12552569, "text": "Eighteen novel mutations have been found in a neurofibromatosis 1 cohort."}, {"pubmed": 12552569, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 12660952, "text": "NF1 microdeletion individuals have a substantially higher lifetime risk for the development of malignant peripheral nerve sheath tumors than individuals with NF1 who do not have an NF1 microdeletion"}, {"pubmed": 12707950, "text": "Neurofibromatosis-Noonan syndrome (NFNS) can in some cases result from different mutations in the NF1 gene."}, {"pubmed": 12730209, "text": "mutual regulation of Ras and NF1-GAP is essential for normal neuronal differentiation"}, {"pubmed": 12746402, "text": "mutations and clinical spectrum in patients with spinal neurofibromas"}, {"pubmed": 12807981, "text": "Recurrent mutations are more common than previously described, being present in 45% of the patients in whom the NF1 causative mutation has been identified."}, {"pubmed": 12872266, "text": "novel NF1 point mutations, deletions, and frameshift mutations causing premature termination and aberrant splicing."}, {"pubmed": 12963615, "text": "Mutations of the NF1 gene may occasionally play a role in the pathogenesis of uveal melanoma."}, {"pubmed": 13679444, "text": "LOH at NF1 may be one of the genetic features seen in peripheral nerve sheath tumors from different locations and should be interpreted with caution"}, {"pubmed": 14647436, "text": "new information concerning the transcriptional regulation of the NF1 gene, and the most thorough attempt to date to map functionally relevant regions within the NF1 proximal promoter region"}, {"pubmed": 14722914, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 14988005, "text": "NF-1 is actively transported to the cell nucleus."}, {"pubmed": 15096131, "text": "Neurofibromin 1 genetic alteration may play a part in the pathogenesis of neurofibromatosis type 1."}, {"pubmed": 15146469, "text": "NF1 mutational spectrum in the Italian population reporting four-year experience with the direct analysis of the whole NF1 coding region in 110 unrelated subjects affected by NF1"}, {"pubmed": 15146469, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 15233998, "text": "molecular evolution and genomic organization"}, {"pubmed": 15371411, "text": "ICSBP1 activates transcription of the gene encoding neurofibromin 1"}, {"pubmed": 15389774, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15523626, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15583390, "text": "preliminary crystallographic characterization of a novel segment (homologous to the yeast Sec14p lipid exchange protein) from the neurofibromatosis type 1 protein"}, {"pubmed": 15627836, "text": "We described a patient with ectropion and the mutation R1748X in the NF1 gene"}, {"pubmed": 15735964, "text": "The differences between normal and NF1 keratinocytes were dependent on extracellular calcium concentration."}, {"pubmed": 15767669, "text": "TBP affects the NF1 and c-fos promoters in a manner reciprocal to that of TLF, stimulating the c-fos promoter and inhibiting NF1 transcription"}, {"pubmed": 15944227, "text": "We performed a comprehensive array-CGH analysis of 161 NF1 derived samples and identified heterozygous deletions of various sizes in 39 cases."}, {"pubmed": 15988004, "text": "NF1 tumor suppressor gene is a direct transcriptional target of RUNX1 and the t(8;21) fusion protein, suggesting that suppression of NF1 expression contributes to the molecular pathogenesis of acute myeloid leukemia ."}, {"pubmed": 16005615, "text": "the NF1 gene is mutated in Chinese Han families with type 1 neurofibromatosis"}, {"pubmed": 16081245, "text": "We now report that the same transition(GC-poor isochore to a GC-rich one in the NF1 gene region )zone separates early replicating from late replicating chromatin on the molecular level"}, {"pubmed": 16138909, "text": "NF1 and Nkx2-5 might be involved in heart development and congenital heart disease"}, {"pubmed": 16169856, "text": "NF1 siRNA induces morphological changes, such as excessive actin stress fiber formation, with elevated negative phosphorylation levels of cofilin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments."}, {"pubmed": 16380919, "text": "NF1 mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome."}, {"pubmed": 16380919, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16405917, "text": "These novel findings provide insight into possible signaling mechanisms of Nf1 and suggest that together Nf1 and Cav-1 may coordinately regulate cell growth and differentiation."}, {"pubmed": 16467218, "text": "Connective tissue dysplasia is common in patients with NF1 microdeletions."}, {"pubmed": 16470740, "text": "a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) is due to intronic sequence exonization [case report]"}, {"pubmed": 16479075, "text": "A genotype- phenotype correlation analysis suggests that there is no clear relationship between specific NF1 mutations and clinical features of the Neurofibromatosis type 1."}, {"pubmed": 16644864, "text": "NF1 is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells"}, {"pubmed": 16741618, "text": "the molecular pathogenesis of GISTs in NF1 patients is different from that in non-NF1 patients."}, {"pubmed": 16773574, "text": "results are the first to document double inactivation of NF1 in pseudoarthrosis tissue and suggest that the neurofibromin-Ras signal transduction pathway is involved in this bone dysplasia in NF1"}, {"pubmed": 16813595, "text": "Physiology, genetics and chemistry. Review."}, {"pubmed": 16830335, "text": "Somatic loss of wild type NF1 allele is associated with neurofibromas"}, {"pubmed": 16835260, "text": "NF1 is a potent novel molecular target for inhibition of neurofibroma formation."}, {"pubmed": 16835897, "text": "45 novel mutations within the NF1 gene are associated with neurofibromatosis type 1."}, {"pubmed": 16908010, "text": "Overexpression of the NF1 GAP-related domain can at least partially reverse the transformation of human NF1 tumor-derived Schwann cells."}, {"pubmed": 16914719, "text": "ICSBP tyrosine phosphorylation is necessary for the activation of NF1 transcription.  ICSBP is a substrate for SHP2 protein tyrosine phosphatase (SHP2-PTP)."}, {"pubmed": 16944271, "text": "This is the first reported occurrence of a gastric carcinoid tumour in a patient with NF1 in the absence of other predisposing factors. The carcinoid arose through NF1 gene inactivation but in the absence of an inherited NF1 gene microdeletion."}, {"pubmed": 16944272, "text": "169 unrelated individuals suspected of having neurofibromatosis type I (NF1) were referred for NF1 diagnostic testing. Possible disease causing mutations were identified in 109 (64%) cases. These comprised 88 sequence alterations, of which 57 were novel."}, {"pubmed": 17053831, "text": "in vitro-differentiated osteoclasts from NF1 patients also displayed elevated Ras/PI3K activity and increased lytic activity analogous to those in murine Nf1(+/-) osteoclasts"}, {"pubmed": 17096025, "text": "Neurofibromin-deficient mouse embryonic fibroblasts (MEFs) and human NF1 tumor cells were more resistant than neurofibromin-expressing cells to apoptosis mediated by two survival pathways: a Ras-dependent pathway, and a Ras-independent pathway."}, {"pubmed": 17102080, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17160901, "text": "There is a correlation of a specific small mutation of the NF1 gene to the expression of a particular clinical phenotype."}, {"pubmed": 17200120, "text": "IRF8 cooperates with PU.1 and IRF-2 to activate a composite ets/IRF-cis element in the NF1 promoter"}, {"pubmed": 17216419, "text": "Variation in Nf1 levels is not responsible for the differences in astrocytoma and peripheral nerve sheath tumor susceptibility."}, {"pubmed": 17295913, "text": "significant proportion of NF1 exon 7 mutations affects pre-mRNA splicing"}, {"pubmed": 17353900, "text": "Uniparental disomy surrounding the NF1 locus is associated with neurofibromatosis"}, {"pubmed": 17404841, "text": "Results suggest that neurofibromin-deficient Schwann cells have dysregulated expression of pro-angiogenic factors, anti-angiogenic factors, growth factor receptors, and an integrin."}, {"pubmed": 17426081, "text": "NF1-related pheochromocytoma was significantly more frequent than in sporadic pheochromocytoma, providing further molecular evidence that pheochromocytoma is a true component of neurofibromatosis 1"}, {"pubmed": 17514731, "text": "A C > T nucleotide change in exon 4b results in a change of glutamine to a stop codon (Q162X). It is a novel NF1 gene alteration."}, {"pubmed": 17563086, "text": "we describe the use of loss of heterozygosity information in neurofibromas to obtain linkage information on the affected NF1 haplotype, which may be applied for prenatal testing in sporadic patients."}, {"pubmed": 17581973, "text": "Expression of human NF1 mutations and deletions in Drosophila mutants shows that GTPase-activating protein-related domain of NF1 is necessary and sufficient for long-term memory, whereas NF1 carboxyl-terminal domain is essential for immediate memory."}, {"pubmed": 17726231, "text": "mutational spectrum of 22 unrelated Czech patients with neurofibromatosis type 1; study found NF1 mutations in 17 patients; twelve of the mutations were newly found"}, {"pubmed": 17876295, "text": "Intraneural injection of the cell line sNF96.2 expressing NF1 consistently produced MPNST-like tumors that were highly cellular and showed extensive intraneural growth."}, {"pubmed": 17880527, "text": "Somatic down-regulation of mismatch repair proteins in nodular-trabecular muscle-invasive bladder urothelial carcinomas results in RB1/NF1 microsatellite abnormalities, correlating with higher cellular turnover and longer survival."}, {"pubmed": 17914445, "text": "There is a statistically significant difference in the frequency of second hit NF1 mutations in cafe au lait spots (CALM) melanocytes compared with CALM fibroblasts, and with CALM keratinocytes."}, {"pubmed": 17960768, "text": "The NF1 germline mutations identified in 22 lymphocytes DNA from these patients included seven novel mutations and a large 1.4-Mb deletion"}, {"pubmed": 17999360, "text": "5% of patients with neurofibromatosis type 1 (NF1) exhibit gross deletions that encompass the NF1 gene and its flanking regions. The breakpoints type 2 deletions are a second type of recurring NF1 gene deletion."}, {"pubmed": 18021924, "text": "This study identified 496delGT and 499delTGTT mutations in exon 4b and 5866delA as a new mutation in exon 31 (Human Gene Mutation Database accession number Hd0524)."}, {"pubmed": 18055911, "text": "Of 23 deletions detected by MLPA, 6 were single exon, 8 were multi-exon, and 9 were of the entire NF1 gene, accounting for approximately 7% (14/201) of the NF1 gene mutation spectrum seen in a 201-patient Italian NF1 cohort."}, {"pubmed": 18086893, "text": "In addition to providing the first mechanistic insight into tissue-specific control of NF1 splicing, these studies establish a novel strategy whereby Hu proteins regulate RNA processing."}, {"pubmed": 18172006, "text": "NF1 inactivation may provide an additional proliferative signal toward the development of leukemia."}, {"pubmed": 18183042, "text": "study reports seven cases of NF1 microduplication within one family; main phenotypic features are mental deficiency, early onset of baldness, dental enamel hypoplasia and minor facial dysmorphism"}, {"pubmed": 18212816, "text": "copy number variations in the NF1 gene region do not appear to be frequent mediators of non-allelic homologous recombination giving rise to type-1 deletions"}, {"pubmed": 18214791, "text": "The responsible gene and its protein product, neurofibromin have been identified."}, {"pubmed": 18215124, "text": "A possible functional relationship between the NF1 and Smad proteins that has not been previously observed."}, {"pubmed": 18218617, "text": "association of neurofibromin and CRMP-2 is essential for neuronal cell differentiation"}, {"pubmed": 18316778, "text": "These experiments show that neurofibromin is expressed at low levels in human osteoblasts and chondrocytes and is located mainly in the cytoplasm."}, {"pubmed": 18331998, "text": "The present study demonstrated that G1336X mutation in the NF1 gene cause Neurofibromatosis type I in the family."}, {"pubmed": 18407053, "text": "R1947X mutation of NF1 may be one of reasons for neurofibromatosis type 1 in Chinese population."}, {"pubmed": 18484666, "text": "analysis of germline and somatic NF1 gene mutations in plexiform neurofibromas"}, {"pubmed": 18485440, "text": "expression of NF1 was significantly reduced in alphavirus-resistant cells"}, {"pubmed": 18503770, "text": "The pathological splicing mutation c.6792C>G in NF1 exon 37 decreases the affinity for the positive splicing factor and increases the affinity for the negative splicing factors."}, {"pubmed": 18511569, "text": "Mosaicism in NF1 associated with neurofibromatosis type 1 is discussed."}, {"pubmed": 18546366, "text": "analysis of 282 NF1 splicing alterations at the DNA and RNA levels"}, {"pubmed": 18592002, "text": "RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1a."}, {"pubmed": 18802710, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18948576, "text": "deregulated Bcl11a cooperates with Nf1 in leukemogenesis"}, {"pubmed": 19041782, "text": "Progenitor sphere formation requires signaling from the EGFR tyrosine kinase. Nf1 loss of function amplifies this progenitor pool, which becomes hypersensitive to growth factors and confers tumorigenesis."}, {"pubmed": 19048115, "text": "the pathways regulated by the NF1 and p53 tumor-suppressor proteins often cooperate in the development of ovarian carcinomas with serous differentiation"}, {"pubmed": 19061981, "text": "This finding may identify a novel mechanism how a single NF1 gene mutation may exert distinct effects on separate anatomical locations."}, {"pubmed": 19120036, "text": "Mutation analysis of NF1 was conducted on patient with severe form of Noonan Syndrome and Cafe-Au-Lait spots, using DNA sequencing. Results suggest mutation NF1 R1809C may be associated Cafe-au-Lait spots."}, {"pubmed": 19142971, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19144660, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19215943, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19220708, "text": "C-tail phosphorylation of neurofibromin correlates with a shift of neurofibromin localization from the nucleus to the cytosol in human neuronal SH-SY5Y cells in vitro."}, {"pubmed": 19221814, "text": "Results describe neurofibromatosis type 1 germline and somatic mutations in spinal neurofibromas."}, {"pubmed": 19238080, "text": "A case report of NF1 with undescribed osseous abnormalities."}, {"pubmed": 19291764, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19292874, "text": "In this study, we evaluated the effect of patient variations in neurofibromatosis type 1 (NF1) exon 29 and its 5'SS surrounding area on its splicing process."}, {"pubmed": 19351817, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19417008, "text": "No significant deviations of transmission of the NF1 variants to the affected neurofibromatosis 1 offspring was found."}, {"pubmed": 19449407, "text": "Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome are reported."}, {"pubmed": 19601812, "text": "Studies indicate that advances in knowledge of the developmental defects primed by the loss neurofibromin should reveal further associations between given NF1 mutations and tissue-specific symptoms, thus improving the clinical management of the patients."}, {"pubmed": 19650418, "text": "The phenotypic variability and the absence of genotype-phenotype correlation create difficulties in reproductive decisions for NF1 families."}, {"pubmed": 19718661, "text": "analysis of the effect on the Ras/Raf signaling pathway of post-translational modifications of neurofibromin"}, {"pubmed": 19773259, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19845691, "text": "NF1 mutations are involved in the etiology of neurofibromatosis-Noonan syndrome."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19940123, "text": "NF1 binding to the MMTV promoter on a H3/H4 histone tetramer particle exposes the central HREs and facilitates their binding by progesterone receptor"}, {"pubmed": 20002172, "text": "neurofibromin regulates the Ras-mediated pathway which plays a crucial role in epithelial-to-mesenchymal transition. Excessive mesenchymal reaction may play a role in the development of NF1-associated neurofibromas."}, {"pubmed": 20006588, "text": "syndecan's interactions with both CASK and neurofibromin are dependent on syndecan homodimerization."}, {"pubmed": 20015894, "text": "The study provides data on the nature of somatic NF1 lesions in juvenile myelomonocytic leukemia and neurofibromatosis type 1 and supports the concept that biallelic inactivation of NF1 function is required for full leukemic transformation."}, {"pubmed": 20052761, "text": "regions of homozygosity at 17q11.2 may havea role in type-2 NF1 deletions"}, {"pubmed": 20082856, "text": "In addition to gains of 1q and 5p, and losses of 10p and 13q14 approximately q22, this tumor had also losses of two regions to which tumor suppressor genes are mapped: 1p36 (SDHB) and 17q11.2 (NF1)"}, {"pubmed": 20124472, "text": "A chemical genetics approach reveals STAT3 as a novel neurofibromin/mTOR pathway signaling molecule, define its action and regulation, and establish STAT3 as a tractable target for future NF1-associated cancer therapy studies."}, {"pubmed": 20129251, "text": "Aberrations and gene expression of EGFR, NF1, and PDGFRA/IDH1 each define the Classical, Mesenchymal, and Proneural subtypes, respectively of glioblastoma multiforme"}, {"pubmed": 20160012, "text": "These findings provide evidence for conserved ubiquitination pathways regulating the RasGAP proteins Ira2 (in yeast) and neurofibromin (in humans)."}, {"pubmed": 20160346, "text": "Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans."}, {"pubmed": 20164853, "text": "Acute myeloid leukemia with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions."}, {"pubmed": 20358387, "text": "analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20422842, "text": "Review on cognitive and developmental manifestation of children with NF1 mutation and the importance of early diagnosis and treatment. [REVIEW]"}, {"pubmed": 20428205, "text": "Pediatric early T-cell precursor leukemia with NF1 deletion shows high-sensitivity to tipifarnib."}, {"pubmed": 20435627, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20442305, "text": "Identification of a class of small molecules that specifically inhibit growth of cells from nervous system tumors and seem to act on NF1-deficient cells through cytoskeletal reorganization correlating to changes in Rho signaling."}, {"pubmed": 20503322, "text": "a disease-causing deletion (c.4773-3622-?_5749+?del) encompassing three NF1 gene exons in individuals with neurofibromatosis type 1 was detected."}, {"pubmed": 20505189, "text": "NF1 null states are present in 7 of 95 (7%) of adult acute myelogenous leukemia"}, {"pubmed": 20513137, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20513137, "text": "Rsults confirmed that a higher incidence of learning disabilities and facial dysmorphism in microdeleted patients compared to patients with intragenic NF1 mutations."}, {"pubmed": 20543202, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20543202, "text": "These findings emphasise the importance of deletion analysis in NF1 since frequent monitoring of tumour presence and growth could potentiate early surgical intervention thereby improving patient survival."}, {"pubmed": 20571392, "text": "Studies indicate that human and mouse NF1/Nf1 gene haploinsufficiency modulates cellular physiology and disease pathogeneses."}, {"pubmed": 20587590, "text": "Loss of NF1 function sensitizes cells to inhibition of mammalian target of rapamycin (mTOR), a downstream effector of Ras activation"}, {"pubmed": 20602485, "text": "NF1 exon 22 mutations were associated with neurofibromatosis type 1."}, {"pubmed": 20624961, "text": "Increased inhibition in medial prefrontal cortex (mPFC) is sufficient to alter persistent activity in a biophysical model of an mPFC microcircuit, suggesting a possible mechanism for Nf1(+/-) working memory deficits."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20655465, "text": "Loss of NF1 activates RAS-MEK signaling, which in turn represses ZNF423, a critical transcriptional coactivator of the retinoic acid receptors; neuroblastomas with low levels of both NF1 and ZNF423 have extremely poor outcome"}, {"pubmed": 20680410, "text": "experiments further confirmed the link between the loss of neurofibromin and increased activity of Ras/MAP kinase pathways and the activation of downstream transcriptional mechanisms in MPNSTs from NF1 patients"}, {"pubmed": 20687928, "text": "NF1 mutations are associated with Malignant Peripheral Nerve Sheath Tumours."}, {"pubmed": 20725927, "text": "Type 2 NF1 deletions caused by intrachromosomal mitotic nonallelic homologous recombination."}, {"pubmed": 20927530, "text": "mutational analysis of the NF1 gene revealed a novel frameshift insertion mutation in exon 4c in an Italian family with Neurofibromatosis type 1"}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21089070, "text": "Study highlights mutations in the Sec14-PH module of NF1 as likely modifiers of important structural regions of neurofibromin that may affect protein-protein interaction on a physiological level"}, {"pubmed": 21142935, "text": "Higher grade of methylation in NF1 is associated with glioma."}, {"pubmed": 21157378, "text": "An increase in neurofibromatosis-1 in optic nerve microglia of transgenic mice is associated with reduced expression of CX3CR1."}, {"pubmed": 21236316, "text": "Our results showed an association with a polymorphism regulating the NF1 gene or other genes during brain development"}, {"pubmed": 21244408, "text": "Children with neurofibromatosis type 1 (NF1) have decreased BMD,1 and in vitro studies of osteoprogenitor cells suggest that NF1 haploinsufficiency directly increases various osteoclastic activities."}, {"pubmed": 21278392, "text": "Mutations within the NF1 gene are associated with the risk of optic pathway glioma development in patients with neurofibromatosis type 1."}, {"pubmed": 21280148, "text": "Of 3500 neurofibromatosis patients, 146 had gross NF1 deletions, 14 of whom displayed somatic mosaicism supporting the idea of a direct relationship between the high new mutation rate in this cancer predisposition syndrome and the frequency of mosaicism."}, {"pubmed": 21283084, "text": "Alterations of the NF1 gene is associated with myelodysplastic syndromes and acute myeloid leukemia."}, {"pubmed": 21337692, "text": "There are additional non-hereditary factors modifying the NF1 phenotype and causing discordancies between monozygotic twins."}, {"pubmed": 21365283, "text": "Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion."}, {"pubmed": 21478499, "text": "Neurofibromin (Nf1) is required for skeletal muscle development."}, {"pubmed": 21551249, "text": "Findings define a tumor suppressor role for Nf1 in the adult and narrow the range of potential neurofibroma-initiating cell populations."}, {"pubmed": 21674567, "text": "A high proportion of S100B(+) cells in NF1-associated neurofibromas express Nfn. Although some neurofibromas include sizable populations of cells that have suffered a second hit at the NF1 locus, other neurofibromas do not."}, {"pubmed": 21728811, "text": "Our case shows a unique combination of NF1 and Jalili syndrome; clinical examination, but also of molecular genetic analysis, which together provide a precise diagnosis."}, {"pubmed": 21732117, "text": "This study did not find that the c.2970-2972 delAAT mutation in in Turkish NF1 patients with mild phenotype but identified two base changes in exon 17 (c.2989A>G and c.2894T>A)."}, {"pubmed": 21782795, "text": "The present finding that NF1/Smad4 repressor complexes are formed through TGF-beta signaling pathways suggests a new, but much broader, role for these complexes in the initiation or maintenance of the growth-inhibited state."}, {"pubmed": 21931722, "text": "analysis of the cell of origin of NF1- and PDGF-driven glioblastomas"}, {"pubmed": 22015770, "text": "Deletion of the tumor-suppressor gene NF1 NF1 deletions occur in 7.3% of de novo acute myeloid leukemia"}, {"pubmed": 22096509, "text": "Data observed in DMD and aging skeletal muscle enrichment in motifs for candidate transcription factors that may coordinate either the immune/fibrosis responses (ETS1, IRF1, NF1) or the mitochondrial metabolism (ESRRA)."}, {"pubmed": 22105171, "text": "Neurofibromin & VCP interact & control dendritic spine density. LRD mutations especially at Y1587 destroy this interaction."}, {"pubmed": 22108604, "text": "Although non-identical somatic mutations involving either the same or adjacent nucleotides were identified in three pairs of tumours from the same patients (P<0.0002), no association was noted between the type of germline and somatic NF1 lesion"}, {"pubmed": 22125493, "text": "these findings show that retrotransposon insertions account for as many as -0.4% of all NF1 mutations."}, {"pubmed": 22190464, "text": "Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cells."}, {"pubmed": 22207399, "text": "Synonymous mutations in exons 7, 38, 50, and 56 of the NF1 gene in this family implies that the third codon has a new single nucleotide polymorphism (SNP) that does not lead to a change in the amino acid coding."}, {"pubmed": 22240541, "text": "The lack of well-defined screening tests for early detection and the nonspecific clinical presentation contributes to a poorer outcome in malignancies associated with NF1."}, {"pubmed": 22241097, "text": "This is the first report comparing the phenotypes of nonrelated individuals with NF1 microduplications. This comparison will allow for further definition of this emerging microduplication syndrome."}, {"pubmed": 22250039, "text": "We have observed mitotic recombination in 22% of molecularly characterized NF1-associated glomus tumors."}, {"pubmed": 22293200, "text": "A direct interaction between Nf1 and the multiprotein complex has further been demonstrated using \"in situ\" proximity ligation assay (PLA)."}, {"pubmed": 22294457, "text": "patients with NF1 deletions do not exhibit a significantly higher internal tumor burden than NF1 patients without such deletions."}, {"pubmed": 22354384, "text": "[review] Deficits in executive functioning are expressed by children with neurofibromatosis type 1 and may complicate treatment, in contrast with the focus of attention problems by children with attention deficit disorder."}, {"pubmed": 22399775, "text": "Activation of adult neural progenitor cells by Nf1 is sufficient to modulate depression- and anxiety-like behaviors."}, {"pubmed": 22412049, "text": "There is a tendency for an NF1 expression shift transition from type II to type I isoform, which could comprise a significant event in the development and progression of sporadic breast cancer."}, {"pubmed": 22488919, "text": "Double inactivation of the Nf1 gene and subsequent clonal growth could be a pathogenic feature of the fibrous hamartoma tissue at least in some of the congenital pseudarthrosis of the tibia."}, {"pubmed": 22573716, "text": "findings indicate that a subset of NF1-deficient GBMs may respond to MEK inhibitors currently being tested in clinical trials"}, {"pubmed": 22581253, "text": "anlaysis of the clinical phenotype associated with mosaic type-2 NF1 microdeletions"}, {"pubmed": 22585738, "text": "Biallelic inactivation of NF1 is associated with sporadic plexiform neurofibroma."}, {"pubmed": 22700876, "text": "Haploinsufficiency or complete loss of Pten dramatically accelerated neurofibroma development and led to the development of higher grade PNSTs in the context of Nf1 loss"}, {"pubmed": 22751498, "text": "show that neurofibromin, the NF1 gene product, is a Spred1-interacting protein that is necessary for Spred1's inhibitory function"}, {"pubmed": 22807134, "text": "Ten NF1 variants deemed to be potentially pathogenic by virtue of significantly elevated levels of activated GTP-bound Ras in comparison to wild-type NF1 protein."}, {"pubmed": 22837079, "text": "identified 23 novel nonallelic homologous recombination-mediated type-2 NF1 deletions"}, {"pubmed": 22925204, "text": "A description of two truncating mutations in exon 37 of NF1, the recurrent c.6792C>A and the novel c.6799C>T change, that occur in cis and segregate with neurofibromatosis type 1."}, {"pubmed": 22945628, "text": "In cell lines from human malignant peripheral nerve sheath tumors driven by NF1 loss, HSF1 was overexpressed & activated, which was required for tumor cell viability."}, {"pubmed": 22962301, "text": "NF1 and SOX9 are the most under- and over-expressed genes in NF1-mutated tumors, respectively."}, {"pubmed": 22965642, "text": "A statistically significant increase of breast cancer incidence occurring in NF1 women."}, {"pubmed": 22965773, "text": "We report the case of a 14-year-old boy with neurofibromatosis type 1 with Noonan-like features, who complained of headache with triventricular hydrocephaly and a heterozygous NF1 point mutation"}, {"pubmed": 23010473, "text": "The NF1 gene constitutes the most frequent target of somatic mutations so far known in sporadic pheochromocytomas."}, {"pubmed": 23047742, "text": "Pulmonary stenosis in Neurofibromatosis type 1 and its related disorders is clearly associated with non-truncating mutations in the NF1 gene."}, {"pubmed": 23077663, "text": "Our results suggest a leukemogenic role of miR-370 through NF1 downregulation in AML cells"}, {"pubmed": 23082153, "text": "Nf1/LIMK2 interaction and inhibition allows to directly connect neurofibromatosis type I to actin cytoskeleton remodeling."}, {"pubmed": 23135915, "text": "Our findings unveil a new epigenetic regulatory process in which Z-DNA/MeCP2/NF1 interaction leads to transcriptional suppression, loss of which results in ADAM-12 overexpression in breast cancer cells."}, {"pubmed": 23145129, "text": "Loss of NF1 induces endothelial cell proliferation."}, {"pubmed": 23165953, "text": "An increased risk of breast cancer for women with NF1 < 50 years old."}, {"pubmed": 23171796, "text": "NF1 is mutated or suppressed in human melanomas that harbor concurrent BRAF mutations, NF1 ablation decreases the sensitivity of melanoma cell lines to BRAF inhibitors, and NF1 is lost in tumors from patients following treatment with these agents."}, {"pubmed": 23222849, "text": "Neuroglial progenitor cell NF1 loss is likely sufficient for pilocytic astrocytoma formation in cooperation with a proper stromal environment."}, {"pubmed": 23244495, "text": "A significant association was apparent between possession of a splice-site mutation and the presence of brain gliomas and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 patients."}, {"pubmed": 23288408, "text": "Authors used a pooled RNA interference screen targeting more than 16,500 genes to discover loss-of-function events that could drive resistance to RAF inhibition. The highest ranking gene was NF1 a tumor suppressor that inhibits RAS activity."}, {"pubmed": 23292448, "text": "our results suggest that upregulation of Bcl-xL in MPNST-derived SCs may be caused by the NF1 deficiency-mediated elevation in Ras/MAPK signaling and may provide a new potential chemotherapeutic target in patients with NF1 and MPNSTs."}, {"pubmed": 23312374, "text": "NF1 provides a unique genetic tool to identify and dissect mechanistically the molecular and cellular bases underlying cognitive dysfunction."}, {"pubmed": 23335975, "text": "Our findings identified miR-193b as a potentially novel prognostic marker in HNSCC that drives tumour progression via down-regulating NF1, in turn leading to activation of ERK."}, {"pubmed": 23407919, "text": "Germline mutations in NF1 gene is associated with pheochromocytoma."}, {"pubmed": 23423222, "text": "Gene expression changes due to neurofibromin modulation but independent of NRAS and MEK1/2 regulation in malignant peripheral nerve sheath tumor cells indicated bone morphogenetic protein 2 (Bmp2) signaling as a key pathway."}, {"pubmed": 23437333, "text": "Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD."}, {"pubmed": 23460398, "text": "Direct NF1 inactivation is infrequent in de novo acute myeloid leukemia and may be a secondary event probably involved in leukemic progression."}, {"pubmed": 23481210, "text": "Data suggest that pheochromocytoma and paraganglioma can be divided into two groups based on mutations, cluster 1 (succinate dehydrogenases/von Hippel-Lindau syndrome protein) and cluster 2 (c-ret proto-oncogene/neurofibromin 1). [REVIEW]"}, {"pubmed": 23528211, "text": "NF1 gene haploinsufficiency in tumor Schwann cells may directly elicit upregulation of VEGF expression without the tumor microenvironment by activation of the mTOR-HIF-1alpha - VEGF pathway."}, {"pubmed": 23583712, "text": "The cytoplasmic Dynein Heavy Chain 1 (DHC) was found to interact with NF1 along microtubules in vesicular structures identified to be melanosomes."}, {"pubmed": 23624750, "text": "Authors indicate that this report is the first of a family with some members clinically affected by neurofibromatosis type 1 and breast cancer, being carriers of both BRCA1 and NF1 mutations."}, {"pubmed": 23668869, "text": "This analysis revealed a wide spectrum of NF1 mutations in Korean patients."}, {"pubmed": 23758643, "text": "We show that Slovak NF1 patients have a similar repertoire of NF1 germline mutations compared to other populations, with some prevalence of small deletions/insertions and a decreased proportion of nonsense mutations."}, {"pubmed": 23906300, "text": "Mutations in the NF1 gene is associated with optic pathway glioma"}, {"pubmed": 23913538, "text": "The association analysis of these mutation types with 12 common NF1 clinical features confirmed a weak contribution of the allelic heterogeneity of the NF1 mutation to the NF1 variable expressivity."}, {"pubmed": 23947441, "text": "The presence of two remotely acting regulatory regions, located, respectively, approximately 600 kb and approximately 42 kb upstream of the NF1 gene, are predicted."}, {"pubmed": 23954459, "text": "Description of a family with extreme phenotypic variability in the spectrum of NF1, linked to a novel missense mutation of the NF1 gene"}, {"pubmed": 24186807, "text": "findings imply mitotic as well as meiotic nonallelic homologous recombination intermediates of large NF1 deletions are processed by long-patch mismatch repair (MMR) ensuring gene conversion tract continuity; however, the single type-2 NF1 deletion not exhibiting continuous gene conversion was processed without MMR, yielding 2 different deletion-bearing chromosomes"}, {"pubmed": 24218100, "text": "The nonsense mutation, c.541C>T, located in the NF1 gene could constitute one genetic factor for cerebral vessel lesions."}, {"pubmed": 24249802, "text": "Visual acuity assessments using consistent quantitative testing methods are recommended as the main functional outcome measure for optic pathway glioma trials of neurofibromin (NF1)."}, {"pubmed": 24296828, "text": "Data show two distinct mechanisms of acquired resistance: acquisition of the T654I gatekeeper mutation in discoidin domain receptor tyrosine kinase 2 (DDR2) and loss of neurofibromin 1 (NF1)."}, {"pubmed": 24334617, "text": "SPRED1 seems to play an important role in recruiting neurofibromin to the plasma membrane. (Review)"}, {"pubmed": 24361808, "text": "A patient affected by a germ-line mutation in both NF1 and RET genes."}, {"pubmed": 24370551, "text": "Neurofibromin-deficient myeloid cells are the cellular triggers for aneurysm formation."}, {"pubmed": 24375753, "text": "Female patients with NF1-associated optic glioma were twice as likely to undergo brain magnetic resonance imaging for visual symptoms and 3x more likely to require treatment for visual decline than their male counterparts"}, {"pubmed": 24413922, "text": "This analysis represents the spectrum of NF1 mutations in United Arab Emirates and supports the premise of absence of hotspot mutations in the NF1 gene"}, {"pubmed": 24509877, "text": "MAF has a role in mediating crosstalk between Ras-MAPK and mTOR signaling in NF1"}, {"pubmed": 24535670, "text": "Low levels of NF1 expression were associated with primary and acquired resistance of lung adenocarcinomas to EGFR Thymidine Kinase Inhibitors in patients."}, {"pubmed": 24576830, "text": "Loss of NF1 is common in cutaneous melanoma and is associated with RAS activation, MEK-dependence, and resistance to RAF inhibition."}, {"pubmed": 24676424, "text": "Provide proof of principle that the sequence capture methodology combined with high-throughput sequencing is applicable to NF1 mutation analysis."}, {"pubmed": 24708790, "text": "NF1 gene mutation is associated with suprarenal solitary fibrous tumor."}, {"pubmed": 24760680, "text": "we show evidence that PATRR17 is a hotspot for pathogenic intragenic deletions within the NF1 gene and suggest a novel replication-dependent mechanism for PATRR-mediated translocation."}, {"pubmed": 24789688, "text": "127 different NF1 mutations and 54 novel mutations detected at both the genomic DNA and mRNA have been described in neurofibromatosis type 1 patients."}, {"pubmed": 24795011, "text": "Study reveals the NF1 tumor suppressor gene as a new mediator of resistance to EGFR tyrosine kinase inhibitors."}, {"pubmed": 24922668, "text": "NF1 truncating mutations are associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies"}, {"pubmed": 24932921, "text": "Significant overexpression of specific cancer-associated genes in pseudoarthrosis highlights a potential for receptor tyrosine kinase inhibitors to target neurofibromin-deficient pseudoarthrosis and promote proper bone remodeling and fracture healing."}, {"pubmed": 25027832, "text": "We believe that the lack of correlation between the MRI findings and the social/emotional parameters of the SDQ is another demonstration of the marked clinical variability characteristic of NF1."}, {"pubmed": 25070947, "text": "Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC zeta activation, which is perturbed in neurofibromatosis type 1."}, {"pubmed": 25078596, "text": "A novel c.702_703delGT frameshift mutation in NF1 is likely to be responsible for the pathogenesis of NF1 in a Chinese family."}, {"pubmed": 25166435, "text": "results indicate that an Multiplex ligation-dependent probe amplification analysis may be performed in patients with a clinical diagnosis of NF1 or patients with suspected NF1 as an easy and inexpensive first molecular test"}, {"pubmed": 25182393, "text": "The review discusses the role of neurofibromin 1 in cell signaling with special attention to RAS/MAPK pathway regulation as well as in organism development in neurofibromaatosis type 1."}, {"pubmed": 25234363, "text": "A previously unreported heterozygous missense mutation c.3443C > A, p.Ala1148Glu in exon 20 in three neurofibromatosis type I patients."}, {"pubmed": 25267367, "text": "We hereby report two cases of male breast cancer with neurofibromatosis."}, {"pubmed": 25370043, "text": "Our finding and revision of the literature consistently indicate that the c.5425C>T change is associated with a distinctive, mild form of NF1, providing new data with direct impact on genetic counseling and patient management."}, {"pubmed": 25403449, "text": "NF1 immunohistochemistry alone is not a sufficient method to distinguish between NF1-mutated and non-mutated pheochromocytoma"}, {"pubmed": 25483400, "text": "Neurofibromatosis type 1 (Nf1) gene activity regulates drinking and ethanol-stimulated GABA release in the mouse central amygdala. NF1 variation may confer an inherent susceptibility to the transition from nondependent to dependent drinking in humans."}, {"pubmed": 25486365, "text": "the C-terminal domains of neurofibromin, Ira1, and Ira2 regulate the metaphase to anaphase transition in a Mad2-independent fashion."}, {"pubmed": 25775093, "text": "Data suggest that bi-allelic loss of Nf1 induces autonomous adrenal hyper-activity. Nf1 seems involved in the regulation of adrenal cortex function in mice and humans."}, {"pubmed": 25786243, "text": "provide novel insights regarding the pathophysiology of dystrophic spinal anomalies in NF1."}, {"pubmed": 25824590, "text": "NF1 loss induces senescence during melanocyte differentiation."}, {"pubmed": 25899471, "text": "Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1."}, {"pubmed": 26076063, "text": "High frequency of NF1 mutations in desmoplastic melanomas suggests an important role for NF1 in the biology of this type of melanoma."}, {"pubmed": 26111455, "text": "The pattern of growth differs substantially in deletion and non-deletion neurofibromatosis 1 patients, but the pathogenic basis for this difference is unknown."}, {"pubmed": 26178382, "text": "Constitutional missense mutations at p.Arg1809 affect 1.23% of unrelated NF1 probands in the UAB cohort, therefore this specific NF1 genotype-phenotype correlation will affect counseling and management of a significant number of patients."}, {"pubmed": 26189818, "text": "A DNA-replication-based mechanisms comprising both fork stalling-and-template switching and/or microhomology-mediated break-induced replication and serial replication stalling is the predominant mechanisms leading to NF1 intragenic copy-number variations."}, {"pubmed": 26190195, "text": "NF1 genetic loss occurs in a subset of diffuse gliomas, and its significance deserves further exploration"}, {"pubmed": 26214590, "text": "NF1 is a key tumor suppressor lost in melanomas."}, {"pubmed": 26345759, "text": "The whole coding sequence of NF1, plus flanking intronic regions, was examined by Sanger sequencing, and four frameshift mutations were identified."}, {"pubmed": 26478990, "text": "proposed technique is cheap and reliable, and could ideally be performed as a preliminary biochemical screening before molecular analysis of the Neurofibromatosis type 1 gene"}, {"pubmed": 26490262, "text": "Neurofibromin protein abundance and nuclear import are mechanistically linked to an error-free chromosome congression."}, {"pubmed": 26509978, "text": "The complexity of the splicing regulatory elements present in exon 9 is most likely responsible for the fact that mutations in this region represent 25% of all exonic changes that affect splicing in the NF1 gene."}, {"pubmed": 26523645, "text": "Inactivation of neurofibromin 1 unlocked a latent oligodendrocyte lineage potential in adult neural stem cells."}, {"pubmed": 26555092, "text": "This study suggests that inactivating NF1 mutations outside the context of neurofibromatosis may be the oncogenic mechanism for a subset of sporadic gastrointestinal stromal tumors"}, {"pubmed": 26614388, "text": "Fine mapping of meiotic NAHR-associated crossovers causing large NF1 deletions has been reported."}, {"pubmed": 26635368, "text": "Data suggest SPRED1 EVH1 domain interacts with NF1 GRD domain [N-term. 16AA/C-term. 20AA of GTPase-activating protein-related domain]; SPRED1 EVH1 and NF1 GRD mutations observed in Legius syndrome reduce binding affinity between EVH1/GRD domains."}, {"pubmed": 26666878, "text": "Of the ten reported cases of NF1 due to R681X, one has presented with optic glioma and none with precocious puberty."}, {"pubmed": 26758488, "text": "mutation in the NF1 gene is associated with Neurofibromatosis-Noonan Syndrome."}, {"pubmed": 26822862, "text": "the computational model results have added credibility to the experimental hypothesis of a genetic cause (i.e. Nf1 mutation) for Congenital pseudarthrosis of the tibia"}, {"pubmed": 26861207, "text": "Neurofibromin mediates Ras deactivation."}, {"pubmed": 26861459, "text": "This study identifies a novel cohort of non-small cell lung cancer defined by NF1 mutation and suggests that ongoing therapeutic targeting strategies for KRAS tumors may also have efficacy in this population."}, {"pubmed": 26962827, "text": "Thirty distinct NF1 mutations were identified in 32 patients. Thirteen mutations were novel and most were frameshift mutations (33.3%)."}, {"pubmed": 26969325, "text": "NF1 mutation is not associated with the risk of optic pathway glioma in Neurofibromatosis type 1 patients."}, {"pubmed": 26980030, "text": "Report incidence of NF1 mutations/allelic loss in desmoplastic melanoma and suggest that the DM subtypes have distinct genetic drivers."}, {"pubmed": 27060315, "text": "Novel 1948delT and 541C>T mutations in NF1 associated with sporadic neurofibromatosis type 1."}, {"pubmed": 27074763, "text": "the results from our work show that the molecular basis of NF1 splicing mutations is diverse. Therefore, molecular characterization at both the gDNA and mRNA levels allowed for a better understanding of gDNA-mRNA correlations of NF1 mutations."}, {"pubmed": 27078850, "text": "3 patients with urachal adenocarcinoma had neurofibromin 1 (NF1) mutations"}, {"pubmed": 27107091, "text": "Results suggest that the Neurofibromatosis 1-Noonan syndrome (NFNS) phenotype may be the result of both a genetic factor of mutation in the neurofibromin 1 gene (NF1) and an epigenetic/environmental factor."}, {"pubmed": 27234610, "text": "A novel frameshift mutation co-segregated with the disease diverse phenotypes among the affected members of a Chinese family."}, {"pubmed": 27313208, "text": "The EVH1 domain of Spred1 binds to the noncatalytic portion of the GAP-related domain of neurofibromin."}, {"pubmed": 27374410, "text": "pathological role of c.853_854insTC mutation suggested"}, {"pubmed": 27418650, "text": "found that homozygous Stat5 deficiency extended the lifespan of Nf1-deficient mice and eliminated the development of myeloproliferative neoplasm associated with Nf1 gene loss"}, {"pubmed": 27477693, "text": "Loss of NF1 is associated with pathogenesis of malignant peripheral nerve sheath tumor."}, {"pubmed": 27482814, "text": "the human nonsense NF1(Arg681*) and missense NF1(Gly848Arg) mutations have different effects on neurofibromin expression in the mouse and each recapitulates unique aspects of the NF1 phenotype."}, {"pubmed": 27494896, "text": "this studies show the ability of miR-10b to activate the expression of c-Jun through RhoC and NF1, which represents a novel pathway for promoting migration and invasion of human cancer cells"}, {"pubmed": 27622733, "text": "review of neurofibromin with special attention to keratinocytes, melanocytes, NF1-related tumors and melanoma [review]"}, {"pubmed": 27630302, "text": "Her-2, N-ras and Nf1 have roles in brain onocogenesis"}, {"pubmed": 27659822, "text": "The findings of this study suggest that the most childhood NF1-associated low-grade gliomas are midline and benign in nature, hemispheric NF1-related gliomas may have a more aggressive biological and clinical behavior."}, {"pubmed": 27798892, "text": "A significant correlation between neurofibromin expression and colorectal tumor localization was found, with tumors arising in the colon showing intense NF expression more often than those arising in the rectum; higher expression of NF was more common in tumors not responding to treatment; and tumors with multiple metastases showed higher expression of NF than those with single metastasis"}, {"pubmed": 27827403, "text": "findings provide a mechanism by which miR-107 regulates NF1 in GC, as well as highlight the importance of interaction between miR-107 and NF1 in GC development and progression"}, {"pubmed": 27838393, "text": "The use of Next Generation Sequencing has proven to be effective as for costs, and time for analysis, and it allowed us to identify a patient with NF1 mosaicism."}, {"pubmed": 27862886, "text": "Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma"}, {"pubmed": 27980226, "text": "NF1 gene mutation is associated with neurofibromatosis type1."}, {"pubmed": 28067895, "text": "Mutations in neurofibromin 1 (NF1) are common in cancer, including melanoma, and targeting NF1-regulated pathways offers potential therapeutic options for the treatment of NF1 and melanoma."}, {"pubmed": 28068329, "text": "Comprehensive genetic analysis reveals the primacy of NF1 loss as the driver of PN tumorigenesis."}, {"pubmed": 28108518, "text": "Low NF1 expression is associated with Triple-Negative Breast Cancer."}, {"pubmed": 28124441, "text": "Loss of NF1 gene is associated with malignant peripheral nerve sheath tumors."}, {"pubmed": 28174230, "text": "Study found that NF1 negatively regulates mTOR signaling in a LAMTOR1-dependent manner. In addition, the cell growth and survival of NF1-deficient cells have become dependent on hyperactivation of the mTOR pathway, and the tumorigenic properties of these cells have become dependent on LAMTOR1."}, {"pubmed": 28213670, "text": "summarise current knowledge about genotype-phenotype relationships in NF1 microdeletion patients and discuss the potential role of the genes located within the NF1 microdeletion interval whose haploinsufficiency may contribute to the more severe clinical phenotype"}, {"pubmed": 28230002, "text": "identified a novel causative NF1 mutation (c.6547_6548insA) in a Chinese family with NF1"}, {"pubmed": 28267273, "text": "the NF1-mutated subtype of melanoma had a higher mutational burden and strongest ultraviolet rays mutation signature."}, {"pubmed": 28296713, "text": "Mutation in NF1 gene is associated with mucosal melanoma."}, {"pubmed": 28380429, "text": "Results show that the NF1 protein negatively regulates Ccl5 expression through suppression of AKT/mTOR signaling."}, {"pubmed": 28380455, "text": "Findings indicate neurofibromin 1 (NF1) as the most frequently occurring driver mutation in mucosal melanoma, and RAS alterations, consisting of NRAS and KRAS mutations, were the second most frequent mutation type."}, {"pubmed": 28422438, "text": "the NF1 phenotype and genotype were similar between children with and without Moyamoya syndrome (MMS). Interestingly, three children experienced tumors with malignant histology or behavior. The presence of two first cousins in our cohort suggested that there may be potential genetic factors, not linked to NF1, with an additional role respect of NF1 might play a role in MMS pathogenesis"}, {"pubmed": 28423318, "text": "Notch is an Nf1 effector."}, {"pubmed": 28454108, "text": "Data indicate that telomere length may play a role in driving genomic instability and clonal progression in neurofibromatosis type 1 neurofibromin 1 (NF1)-associated malignant peripheral nerve sheath tumors (MPNSTs)."}, {"pubmed": 28498454, "text": "The fusion transcript codes for a protein in which the last 114 amino acids of SETD2, i.e., the entire Set2 Rpb1 interacting (SRI) domain of SETD2, are replaced by 30 amino acids encoded by the NF1 sequence."}, {"pubmed": 28515046, "text": "In conclusion, using a panel including 17 susceptibility genes, we documented the presence of somatic mutations in over 50% of pheochromocytomas and paragangliomas (PPGL). We confirmed the high frequency of NF1 somatic mutations and identified KIF1B as the second most frequently mutated gene in PPGL tissues."}, {"pubmed": 28637487, "text": "The identification of high frequency of somatic NF1 mutations in sporadic tumours indicates that neurofibromin is likely to play a critical role in development, far beyond that evident in the tumour predisposition syndrome Neurofibromatosis type 1. [Review]"}, {"pubmed": 28646022, "text": "In a coclinical trial to examine how the tumor microenvironment influences the response to multiagent chemotherapy, we found that stromal Nf1 status had no effect."}, {"pubmed": 28804759, "text": "A revised exon nomenclature system for NF1 is proposed based on the CDS coordinates of NM_000267.3ENST00000356175.7. This nomenclature differs from one in active use in the clinical community and represented on the Locus Reference Genomic sequence LRG_214/NG_009018.1."}, {"pubmed": 28961165, "text": "This study retrospectively re-evaluated all NF1 gene variants found in 17 years of diagnostic activity and selected all the mutations not reported in the international databases or in the medical literature. Those latter were stratified according to the five pathogenetic classes, analyzed for their type and their distribution in the exons of the NF1 gene and in the domains of the relative protein."}, {"pubmed": 29127119, "text": "Cancer genomic and functional data nominate concurrent RASA1/NF1 loss-of-function mutations as a strong mitogenic driver in NSCLC, which may sensitize to trametinib"}, {"pubmed": 29185159, "text": "the somatic second hit in the NF1 gene sensitizes Schwann cells to sex hormones resulting in a highly increased proliferation."}, {"pubmed": 29266342, "text": "Study demonstrates that NF1 plays a crucial role in the osteogenic differentiation of bone marrow stem cells (BMSCs), and mTORC1 signaling is essential for NF1-modulated osteogenic differentiation of BMSCs."}, {"pubmed": 29290338, "text": "A genotype-phenotype correlation at the NF1 region 844-848 exists and will be valuable in the management and genetic counseling of a significant number of individuals."}, {"pubmed": 29367450, "text": "Findings suggest that the specific germline NF1 mutation is one modifier of quantitative autistic trait severity which, in combination with other to-be-identified risk factors, may allow for early risk stratification prior to the onset of clinically detectable autism spectrum disorder (ASD) symptomatology. Mutations within the coding region of the 5'-end are associated with higher odds of having lower ASD symptom burden."}, {"pubmed": 29392777, "text": "Deletion of NF1 leads to mutant oligodendrocyte precursor cell (OPC) expansion through increased proliferation and decreased differentiation, the deletion of p53 impairs OPC senescence. Signaling analysis showed that, while PI3K and MEK pathways go through stepwise over-activation, mTOR signaling remains at the basal level in pre-transforming mutant OPCs but is abruptly up-regulated in tumor OPCs."}, {"pubmed": 29449315, "text": "we conclude that increased allelic imbalance of the pathogenic SNV in NF1 likely contributed to tumorigenesis. Our results highlight a need to assess predisposing genetic factors and LOH that can cause rare, aggressive diseases such as MBC in NF1."}, {"pubmed": 29471550, "text": "Mutation spectrum of the NF1 gene is similar to previously reported, confirming the absence of hot spot regions and obvious genotype-phenotype correlations. Despite its limited predictive utility, genetic analysis is interesting for early diagnosis and in the case of atypical presentation of the disease. This study reports different atypical presentation."}, {"pubmed": 29483232, "text": "The most common gene in which a likely causal mutation was detected was NF1 - 6 families with Midaortic Syndrome."}, {"pubmed": 29493886, "text": "Our findings suggest that increased expression of miR-641 significantly contributes to erlotinib resistance development in NSCLC cells through activating ERK signaling by targeting NF1 and that inhibition of miR-641 may reverse acquired resistance of NSCLC cells to erlotinib treatment."}, {"pubmed": 29498099, "text": "Study found that a large number of cutaneous neurofibromas develop in patients with large NF1 deletions beyond age-appropriate incidence, which would be a clue for diagnosis of a severe phenotype of neurofibromatosis 1."}, {"pubmed": 29522274, "text": "We created mutant cDNAs representing NF1 patient variants with different clinically relevant phenotypes, and assessed their ability to produce mature neurofibromin and restore Nf1 activity in NF1(-/-) cells."}, {"pubmed": 29559732, "text": "Similar to cutaneous melanomas, conjunctival melanomas can be grouped genetically into four groups: BRAF-mutated, RAS-mutated, NF1-mutated and triple wild-type melanomas. This genetic classification may be useful for assessment of therapeutic options for patients with metastatic conjunctival melanoma."}, {"pubmed": 29643433, "text": "Overall, this study identifies candidate changes in secreted proteins from NF1 deficient glioma cells that could influence the tumor microenvironment, and suggests a direct link between NF1 loss and increased tumor cell production of CHI3L1 and endoglin, two factors implicated in mesenchymal identity in glioblastoma."}, {"pubmed": 29680440, "text": "novel mutations in the exon 4 and exon 7 of NF1 gene in these families correlating with genotype-phenotype characters explaining the neurofibromatosis type 1 and peripheral nerve sheath tumours condition in these patients."}, {"pubmed": 29703253, "text": "Our results demonstrated that SMAD4 and NF1 mutations can serve as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese mCRC patients."}, {"pubmed": 29730711, "text": "Our findings indicate a strong maternal parent-of-origin bias for type-1 NF1 deletions. A similarly pronounced maternal transmission bias has been reported for recurrent copy number variants (CNVs) within 16p11.2 associated with autism, but not so far for any other NAHR-mediated pathogenic CNVs"}, {"pubmed": 29760048, "text": "Tipifarnib effectively inhibits oncogenic HRAS-driven tumorigenesis and abrogating adaptive signaling improves responses. NF1 and GNAS mutations drive acquired resistance to Hras inhibition, supporting the on-target effects of the drug"}, {"pubmed": 29872168, "text": "CR rates were also lower in NF1-mutated patients aged >/=60 years."}, {"pubmed": 29914388, "text": "The novel mutations identified broaden the spectrum of NF1 mutations in Chinese."}, {"pubmed": 29921698, "text": "analysis of glioblastoma alterations such as IDH mutation, NF1 inactivation, and CDK4-MARCH9 locus amplification"}, {"pubmed": 30014477, "text": "study of NF1 mutations in Spanish patients"}, {"pubmed": 30046999, "text": "A recurrent missense variant c.269T>C (p.Leu90Pro) and a novel nonsense variant c.2993dupA (p.Tyr998*) in the NF1 gene were identified in two Chinese families with neurofibromatosis type 1."}, {"pubmed": 30098238, "text": "four novel mutations identified as causative mutations in patients with sporadic-type neurofibromatosis type 1"}, {"pubmed": 30098240, "text": "Two novel mutations of the NF1 gene were identified in the two neurofibromatosis type 1 patients but not among their unaffected parents"}, {"pubmed": 30104415, "text": "Study of breast cancer specimens from women affected with neurofibromatosis type 1 demonstrates that both germline and somatic NF1 mutations associate with an increase in HER2 expression, resulting from either gene amplification or transcriptional upregulation. This finding suggests a synergistic interplay between these two genes, potentially driving the development of breast cancer."}, {"pubmed": 30104724, "text": "SHP2 has a critical function in promoting oncogenic RAS/MAPK pathway activation in cancers with RAS-GTP-dependent oncogenic BRAF, NF1 loss and nucleotide-cycling oncogenic KRAS."}, {"pubmed": 30190611, "text": "We demonstrate that individuals with the NF1 p.Met992del pathogenic variant have a mild NF1 phenotype lacking clinically suspected plexiform, cutaneous, or subcutaneous neurofibromas. However, learning difficulties are clearly part of the phenotypic presentation in these individuals and will require specialized care."}, {"pubmed": 30230541, "text": "NF1 mutations define a unique molecular and clinicopathologic subtype of lung adenocarcinoma."}, {"pubmed": 30280776, "text": "Results show that NF1 is highly expressed in non-small cell lung cancer (NSCLC) tissues and cell lines. In addition, H19 regulates NF1 expression through competitive binding to microRNA-107, thereafter participating in NSCLC development."}, {"pubmed": 30308447, "text": "Study identified genetic causes underlying Neurofibromatosis Type 1, possible phenotype/genotype correlations and mutation spectrum. A screening protocol based on genomic DNA was established in 168 patients. A germline variant was identified in 145 patients (86%). In total 49 known and 70 novel variants in coding and non-coding regions were identified. Seven patients carried whole or partial gene deletions."}, {"pubmed": 30408279, "text": "The NF1 isoforms expressed from the minigenes showed Ras-GAP activity in vivo and in vitro, while the type 1 was more potent. Our constructs expand currently available full-length NF1 constructs and should be valuable tools in expediting the understanding of NF1, particularly the isoform-specific functions and regulation"}, {"pubmed": 30423024, "text": "Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer."}, {"pubmed": 30478644, "text": "Germline deletion in PITX2 gene is associated with type-1 NF1."}, {"pubmed": 30479396, "text": "an antagonistic role for NF1 heterozygosity in tumor initiation and malignant transformation and helps to reconciliate the role of the NF1 gene in both NF1 and non-NF1 patient contexts, is reported."}, {"pubmed": 30530636, "text": "The type of heritable NF1 mutation is a determinant of breast cancer risk in neurofibromatosis type 1."}, {"pubmed": 30543142, "text": "NF1 knockdown endowed ovarian cells with resistance to cisplatin-induced apoptosis by targeting MCL1 via miR-142-5p"}, {"pubmed": 30549028, "text": "The findings strongly suggest that pathogenic hotspot KRAS, FGFR1 and NF1 mutations underlie the vast majority of non-ossifying fibroma of the bone."}, {"pubmed": 30610056, "text": "Frameshift Mutation of Neurofibromin 1 gene is associated with Neurofibromatosis Type 1"}, {"pubmed": 30703230, "text": "c.1733T>C mutation of the NF1 gene probably underlies the neurofibromatosis type I in this family"}, {"pubmed": 30778836, "text": "NF1 somatic mutation was identified in two patients with dystrophic scoliosis."}, {"pubmed": 30967630, "text": "results show, for the first time, that NF1-leucine-rick domain (LRD) inhibits glioma invasion, and provides evidence of a previously unrecognized function of NF1-LRD in glioma biology"}, {"pubmed": 30977107, "text": "the NF1 germline mutation may also increase the risk of the NF1 germline mutation may also increase the risk of blastic plasmacytoid dendritic cell neoplasm"}, {"pubmed": 31036704, "text": "Nf1 loss promotes Kras-driven lung adenocarcinoma and results in Psat1-mediated glutamate dependence."}, {"pubmed": 31053152, "text": "HMGA2 knockdown regulates autophagy via MSI2-Beclin1 interactions to inhibit NF1 Malignant peripheral nerve sheath tumours (MPNSTs)growth, revealing potential therapeutic targets for these untreatable tumours."}, {"pubmed": 31199580, "text": "Study found that 17.5% of lung adenocarcinoma were NF1 mutations and 8% were NF1 deletions. These NF1 alterations define a distinct clinical and molecular entity of lung adenocarcinoma."}, {"pubmed": 31234911, "text": "the enriched expression of NF1 in inhibitory neurons may underlie inhibitory neuron-specific deficits in NF1."}, {"pubmed": 31250151, "text": "Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1."}, {"pubmed": 31401120, "text": "These data provide structural insight into the interaction of Spred1 and neurofibromin."}, {"pubmed": 31466283, "text": "Affinity purification shows physical binding of NF1 to keratins and NF1 oligomerization."}, {"pubmed": 31533651, "text": "Considering that 6 mutations were novel, comprehensive NF1 mutation analysis is required or necessary or proposed for genetic counselling"}, {"pubmed": 31591187, "text": "Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance."}, {"pubmed": 31595648, "text": "Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1."}, {"pubmed": 31647501, "text": "Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy."}, {"pubmed": 31776437, "text": "These results suggest that NF1 mutation types are associated not only with higher prevalence of severe phenotypes in NF1 but also with their earlier onset."}, {"pubmed": 31836666, "text": "Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer."}, {"pubmed": 31886188, "text": "the data strongly advocate the c.541dupC (p.(Gln181Profs *20)) variant as the underlying genetic cause of the Chinese family with NF1. Moreover, our findings broaden the spectrum of NF1 variants and provide molecular insights into the pathogenesis of NF1"}, {"pubmed": 31979111, "text": "In-silico Analysis of NF1 Missense Variants in ClinVar: Translating Variant Predictions into Variant Interpretation and Classification."}, {"pubmed": 32026187, "text": "Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders."}, {"pubmed": 32098826, "text": "Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAF(V600) -Wild-Type Colorectal Cancer."}, {"pubmed": 32126153, "text": "AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3' splice site mutations outside the canonical AG-dinucleotides."}, {"pubmed": 32142667, "text": "NF1 loss correlates with poor patient outcome in estrogen receptor positive breast cancer.NF1 is a dual repressor for both Ras and estrogen receptor signaling."}, {"pubmed": 32243842, "text": "Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations."}, {"pubmed": 32252413, "text": "Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs."}, {"pubmed": 32352596, "text": "Neurofibromatosis type 1 due to possible maternal mosaicism in a family with two affected siblings."}, {"pubmed": 32353955, "text": "New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors."}, {"pubmed": 32405727, "text": "Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1."}, {"pubmed": 32439933, "text": "Translating current basic research into future therapies for neurofibromatosis type 1."}, {"pubmed": 32447321, "text": "Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma."}, {"pubmed": 32571896, "text": "Haploinsufficiency of the NF1 gene is associated with protection against diabetes."}, {"pubmed": 32575496, "text": "Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients."}, {"pubmed": 32767931, "text": "NF1, Neurofibromin and Gene Therapy: Prospects of Next-Generation Therapy."}, {"pubmed": 33046013, "text": "Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: a case report."}, {"pubmed": 33078527, "text": "Moyamoya syndrome in a child with Legius syndrome: Introducing a cerebral vasculopathy to the SPRED1 phenotype?"}, {"pubmed": 33187641, "text": "The GTPase-activating protein-related domain of neurofibromin interacts with MC1R and regulates pigmentation-mediated signaling in human melanocytes."}, {"pubmed": 33221173, "text": "Clinical Characteristics, Treatments, and Concurrent Mutations in Non-Small Cell Lung Cancer Patients With NF1 Mutations."}, {"pubmed": 33230298, "text": "Integrated molecular drivers coordinate biological and clinical states in melanoma."}, {"pubmed": 33231931, "text": "Empirically downgrading 10 constitutional missense variants of the NF1 gene based on co-existing truncating variants."}, {"pubmed": 33293695, "text": "MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK."}, {"pubmed": 33415784, "text": "Clinical diagnosis of neurofibromatosis type I in multiple family members due to cosegregation of a unique balanced translocation with disruption of the NF1 locus: Testing considerations for accurate diagnosis."}, {"pubmed": 33422488, "text": "NF1 and PTEN gene polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population: A case-control study."}, {"pubmed": 33443663, "text": "Evaluation of clinical findings and neurofibromatosis type 1 bright objects on brain magnetic resonance images of 60 Turkish patients with NF1 gene variants."}, {"pubmed": 33476564, "text": "The isolated GTPase-activating-protein-related domain of neurofibromin-1 has a low conformational stability in solution."}, {"pubmed": 33484105, "text": "Circulating free DNA in the plasma of individuals with neurofibromatosis type 1."}, {"pubmed": 33570696, "text": "MiR-27a-3p/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1."}, {"pubmed": 33574490, "text": "Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation."}, {"pubmed": 33911094, "text": "Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum."}, {"pubmed": 33951044, "text": "Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth."}, {"pubmed": 33999308, "text": "Phenotypic and genetic characterization of novel variant in the NF1 gene underlying neurofibromatosis type 1 in five Chinese families."}, {"pubmed": 34021083, "text": "Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer."}, {"pubmed": 34080803, "text": "Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1."}, {"pubmed": 34184824, "text": "Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1."}, {"pubmed": 34284238, "text": "Intact procedural learning and motor intracortical inhibition in adult neurofibromatosis type 1 gene carriers."}, {"pubmed": 34399888, "text": "NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1."}, {"pubmed": 34418705, "text": "Mutation spectrum of the NF1 gene and genotype-phenotype correlations in Turkish patients: Seventeen novel pathogenic variants."}, {"pubmed": 34427956, "text": "Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I."}, {"pubmed": 34530870, "text": "R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells."}, {"pubmed": 34547192, "text": "Intragenic NF1 deletions in sinonasal mucosal malignant melanoma."}, {"pubmed": 34596808, "text": "Novel germinal mutation in NF1: case report."}, {"pubmed": 34681033, "text": "Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions."}, {"pubmed": 34694046, "text": "Analysis of patient-specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicine."}, {"pubmed": 34707296, "text": "The structure of neurofibromin isoform 2 reveals different functional states."}, {"pubmed": 34779495, "text": "Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance."}, {"pubmed": 34887559, "text": "The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1."}, {"pubmed": 34928431, "text": "Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants."}, {"pubmed": 34948100, "text": "Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor."}, {"pubmed": 35024939, "text": "Case series of congenital pseudarthrosis of the tibia unfulfilling neurofibromatosis type 1 diagnosis: 21% with somatic NF1 haploinsufficiency in the periosteum."}, {"pubmed": 35188187, "text": "RAS and beyond: the many faces of the neurofibromatosis type 1 protein."}, {"pubmed": 35538247, "text": "Optic pathway glioma and endocrine disorders in patients with and without NF1."}, {"pubmed": 35613620, "text": "ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1."}, {"pubmed": 35702826, "text": "Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients."}, {"pubmed": 35885913, "text": "Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype."}, {"pubmed": 35941319, "text": "Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1."}, {"pubmed": 36689660, "text": "Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization."}, {"pubmed": 36760809, "text": "Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma."}, {"pubmed": 36908940, "text": "Splicing annotation of endometrial cancer GWAS risk loci reveals potentially causal variants and supports a role for NF1 and SKAP1 as susceptibility genes."}, {"pubmed": 36973520, "text": "Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes."}, {"pubmed": 37062455, "text": "Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma."}, {"pubmed": 37075699, "text": "Exploiting metabolic vulnerabilities in breast cancers with NF1 loss."}, {"pubmed": 37081086, "text": "The therapeutic potential of neurofibromin signaling pathways and binding partners."}, {"pubmed": 37088138, "text": "Detecting Low-Variant Allele Frequency Mosaic Pathogenic Variants of NF1, TSC2, and AKT3 Genes from Blood in Patients with Neurodevelopmental Disorders."}, {"pubmed": 37147639, "text": "The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1."}, {"pubmed": 37186028, "text": "Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II."}, {"pubmed": 37301319, "text": "Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1."}, {"pubmed": 37471196, "text": "Neurological comorbidities and novel mutations in Turkish cases with neurofibromatosis type 1."}, {"pubmed": 37515639, "text": "Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis-a case report."}, {"pubmed": 37562365, "text": "Childhood-Onset Refractory Hypertension Results from Neurofibromatosis Type 1 Caused by a Splicing NF1 Mutation."}, {"pubmed": 37608248, "text": "Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory."}, {"pubmed": 37614007, "text": "Differential Gene Expression Profiles and Pathways Highlight the Role of Osteoimmunology in Neurofibromatosis Type 1-Related Dystrophic Scoliosis With Osteopenia."}, {"pubmed": 37743642, "text": "IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner."}, {"pubmed": 37806041, "text": "Evaluation of Molecular and Clinical Findings in Children With Neurofibromatosis Type 1: Identification of 15 Novel Variants."}, {"pubmed": 37945316, "text": "Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup."}, {"pubmed": 37990867, "text": "Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia."}, {"pubmed": 37996843, "text": "Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey."}, {"pubmed": 38127282, "text": "Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression."}, {"pubmed": 38154814, "text": "Breast cancer risk in NF1-deleted patients."}, {"pubmed": 38216123, "text": "NF1 deficiency drives metabolic reprogramming in ER+ breast cancer."}, {"pubmed": 38448021, "text": "[Analysis of NF1 gene variants in a Chinese pedigree and a sporadic patient with Neurofibromatosis type 1]."}, {"pubmed": 38603649, "text": "NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor."}, {"pubmed": 38874808, "text": "Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes."}, {"pubmed": 38924432, "text": "MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells."}, {"pubmed": 38954284, "text": "A Comprehensive Overview of NF1 Mutations in Iranian Patients."}], "genomic_pos": {"chr": "17", "end": 31382116, "ensemblgene": "ENSG00000196712", "start": 31094927, "strand": 1}, "genomic_pos_hg19": {"chr": "17", "end": 29709134, "start": 29421945, "strand": 1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0000165", "qualifier": "involved_in", "term": "MAPK cascade"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001649", "qualifier": "involved_in", "term": "osteoblast differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001656", "qualifier": "involved_in", "term": "metanephros development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001666", "qualifier": "involved_in", "term": "response to hypoxia"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001889", "qualifier": "involved_in", "term": "liver development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001935", "qualifier": "involved_in", "term": "endothelial cell proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001937", "pubmed": 16648142, "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of endothelial cell proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001937", "pubmed": 17404841, "qualifier": "involved_in", "term": "negative regulation of endothelial cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001938", "qualifier": "involved_in", "term": "positive regulation of endothelial cell proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001952", "qualifier": "involved_in", "term": "regulation of cell-matrix adhesion"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001953", "qualifier": "involved_in", "term": "negative regulation of cell-matrix adhesion"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002686", "qualifier": "involved_in", "term": "negative regulation of leukocyte migration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006469", "qualifier": "involved_in", "term": "negative regulation of protein kinase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006606", "qualifier": "involved_in", "term": "protein import into nucleus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007154", "qualifier": "involved_in", "term": "cell communication"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007265", "qualifier": "involved_in", "term": "Ras protein signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007405", "qualifier": "involved_in", "term": "neuroblast proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007406", "qualifier": "involved_in", "term": "negative regulation of neuroblast proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007420", "qualifier": "involved_in", "term": "brain development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007422", "qualifier": "involved_in", "term": "peripheral nervous system development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007507", "qualifier": "involved_in", "term": "heart development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007519", "qualifier": "involved_in", "term": "skeletal muscle tissue development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0008542", "qualifier": "involved_in", "term": "visual learning"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008625", "qualifier": "involved_in", "term": "extrinsic apoptotic signaling pathway via death domain receptors"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010468", "qualifier": "involved_in", "term": "regulation of gene expression"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010626", "qualifier": "involved_in", "term": "negative regulation of Schwann cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014010", "qualifier": "involved_in", "term": "Schwann cell proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0014044", "qualifier": "involved_in", "term": "Schwann cell development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016525", "qualifier": "involved_in", "term": "negative regulation of angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016601", "qualifier": "involved_in", "term": "Rac protein signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021510", "qualifier": "involved_in", "term": "spinal cord development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021764", "qualifier": "involved_in", "term": "amygdala development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021897", "qualifier": "involved_in", "term": "forebrain astrocyte development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021915", "qualifier": "involved_in", "term": "neural tube development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021987", "qualifier": "involved_in", "term": "cerebral cortex development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0022011", "qualifier": "involved_in", "term": "myelination in peripheral nervous system"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030036", "qualifier": "involved_in", "term": "actin cytoskeleton organization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030198", "qualifier": "involved_in", "term": "extracellular matrix organization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030199", "qualifier": "involved_in", "term": "collagen fibril organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030316", "qualifier": "involved_in", "term": "osteoclast differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030325", "qualifier": "involved_in", "term": "adrenal gland development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030336", "pubmed": 16648142, "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032228", "qualifier": "involved_in", "term": "regulation of synaptic transmission, GABAergic"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033024", "qualifier": "involved_in", "term": "mast cell apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033027", "qualifier": "involved_in", "term": "positive regulation of mast cell apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034605", "qualifier": "involved_in", "term": "cellular response to heat"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035021", "qualifier": "involved_in", "term": "negative regulation of Rac protein signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0036135", "qualifier": "involved_in", "term": "Schwann cell migration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042060", "qualifier": "involved_in", "term": "wound healing"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042308", "qualifier": "involved_in", "term": "negative regulation of protein import into nucleus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043065", "qualifier": "involved_in", "term": "positive regulation of apoptotic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043087", "pubmed": 1570015, "qualifier": "involved_in", "term": "regulation of GTPase activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043407", "qualifier": "involved_in", "term": "negative regulation of MAP kinase activity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043409", "pubmed": 16648142, "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of MAPK cascade"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043409", "qualifier": "involved_in", "term": "negative regulation of MAPK cascade"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043473", "qualifier": "involved_in", "term": "pigmentation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043491", "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043525", "qualifier": "involved_in", "term": "positive regulation of neuron apoptotic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043535", "pubmed": 17404841, "qualifier": "involved_in", "term": "regulation of blood vessel endothelial cell migration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043547", "pubmed": 2121371, "qualifier": "involved_in", "term": "positive regulation of GTPase activity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043547", "pubmed": 16648142, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of GTPase activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043547", "qualifier": "involved_in", "term": "positive regulation of GTPase activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045124", "qualifier": "involved_in", "term": "regulation of bone resorption"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045671", "qualifier": "involved_in", "term": "negative regulation of osteoclast differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045685", "qualifier": "involved_in", "term": "regulation of glial cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045762", "qualifier": "involved_in", "term": "positive regulation of adenylate cyclase activity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045765", "pubmed": 17404841, "qualifier": "involved_in", "term": "regulation of angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046580", "qualifier": "involved_in", "term": "negative regulation of Ras protein signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046929", "qualifier": "involved_in", "term": "negative regulation of neurotransmitter secretion"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048144", "qualifier": "involved_in", "term": "fibroblast proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048147", "qualifier": "involved_in", "term": "negative regulation of fibroblast proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048169", "qualifier": "involved_in", "term": "regulation of long-term neuronal synaptic plasticity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048485", "qualifier": "involved_in", "term": "sympathetic nervous system development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048593", "qualifier": "involved_in", "term": "camera-type eye morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048709", "qualifier": "involved_in", "term": "oligodendrocyte differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048712", "qualifier": "involved_in", "term": "negative regulation of astrocyte differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048715", "qualifier": "involved_in", "term": "negative regulation of oligodendrocyte differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048745", "qualifier": "involved_in", "term": "smooth muscle tissue development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048820", "qualifier": "involved_in", "term": "hair follicle maturation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048844", "qualifier": "involved_in", "term": "artery morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048853", "qualifier": "involved_in", "term": "forebrain morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050890", "pubmed": 17299016, "qualifier": "involved_in", "term": "cognition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051402", "qualifier": "involved_in", "term": "neuron apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060291", "qualifier": "involved_in", "term": "long-term synaptic potentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061534", "qualifier": "involved_in", "term": "gamma-aminobutyric acid secretion, neurotransmission"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061535", "qualifier": "involved_in", "term": "glutamate secretion, neurotransmission"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070372", "qualifier": "involved_in", "term": "regulation of ERK1 and ERK2 cascade"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070662", "qualifier": "involved_in", "term": "mast cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070667", "qualifier": "involved_in", "term": "negative regulation of mast cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072089", "qualifier": "involved_in", "term": "stem cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097192", "qualifier": "involved_in", "term": "extrinsic apoptotic signaling pathway in absence of ligand"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097529", "qualifier": "involved_in", "term": "myeloid leukocyte migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0098597", "qualifier": "involved_in", "term": "observational learning"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0099175", "qualifier": "involved_in", "term": "regulation of postsynapse organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1900148", "qualifier": "involved_in", "term": "negative regulation of Schwann cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1900271", "qualifier": "involved_in", "term": "regulation of long-term synaptic potentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904707", "qualifier": "involved_in", "term": "positive regulation of vascular associated smooth muscle cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904738", "qualifier": "involved_in", "term": "vascular associated smooth muscle cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904753", "qualifier": "involved_in", "term": "negative regulation of vascular associated smooth muscle cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1990874", "qualifier": "involved_in", "term": "vascular associated smooth muscle cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2000647", "qualifier": "involved_in", "term": "negative regulation of stem cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2001241", "qualifier": "involved_in", "term": "positive regulation of extrinsic apoptotic signaling pathway in absence of ligand"}], "CC": [{"evidence": "ISS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 1550670, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005737", "pubmed": 1550670, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030424", "pubmed": 1550670, "qualifier": "located_in", "term": "axon"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030425", "pubmed": 1550670, "qualifier": "located_in", "term": "dendrite"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098793", "qualifier": "located_in", "term": "presynapse"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098978", "qualifier": "located_in", "term": "glutamatergic synapse"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0005096", "pubmed": [1568247, 1570015, 2121371], "qualifier": "enables", "term": "GTPase activator activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11356864, 16374483, 23027611, 26635368, 30194290, 34626534], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008429", "pubmed": 17187824, "qualifier": "enables", "term": "phosphatidylethanolamine binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031210", "pubmed": 17187824, "qualifier": "enables", "term": "phosphatidylcholine binding"}]}, "homologene": {"genes": [[9606, 4763]], "id": 141252}, "interpro": [{"desc": "Armadillo-type fold", "id": "IPR016024", "short_desc": "ARM-type_fold"}, {"desc": "Protein furry/Tao3/Mor2", "id": "IPR039867", "short_desc": "Furry/Tao3/Mor2"}, {"desc": "CRAL-TRIO lipid binding domain", "id": "IPR001251", "short_desc": "CRAL-TRIO_dom"}, {"desc": "Ras GTPase-activating domain", "id": "IPR001936", "short_desc": "RasGAP_dom"}, {"desc": "Rho GTPase activation protein", "id": "IPR008936", "short_desc": "Rho_GTPase_activation_prot"}, {"desc": "PH-like domain superfamily", "id": "IPR011993", "short_desc": "PH-like_dom_sf"}, {"desc": "Ras GTPase-activating protein, conserved site", "id": "IPR023152", "short_desc": "RasGAP_CS"}, {"desc": "CRAL-TRIO lipid binding domain superfamily", "id": "IPR036865", "short_desc": "CRAL-TRIO_dom_sf"}, {"desc": "Ras GTPase-activating protein", "id": "IPR039360", "short_desc": "Ras_GTPase"}], "ipi": ["IPI00220513", "IPI00220514", "IPI00299512", "IPI00304235", "IPI00909675", "IPI00910794"], "map_location": "17q11.2", "name": "neurofibromin 1", "other_names": ["neurofibromatosis 1", "neurofibromatosis-related protein NF-1", "neurofibromin"], "pantherdb": {"HGNC": "7765", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97306", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 10090, "uniprot_kb": "Q04690"}, {"RGD": "3168", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 10116, "uniprot_kb": "P97526"}, {"Ensembl": "ENSGALG00000005660", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 9031, "uniprot_kb": "E1C9F6"}, {"ZFIN": "ZDB-GENE-091111-4", "ortholog_type": "O", "panther_family": "PTHR10194", "taxid": 7955, "uniprot_kb": "E7FFY1"}, {"ZFIN": "ZDB-GENE-030131-4907", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 7955, "uniprot_kb": "E7FBD0"}, {"FlyBase": "FBgn0015269", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 7227, "uniprot_kb": "Q9VBJ2"}, {"SGD": "S000005441", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 4932, "uniprot_kb": "P19158"}, {"SGD": "S000000344", "ortholog_type": "LDO", "panther_family": "PTHR10194", "taxid": 4932, "uniprot_kb": "P18963"}, {"dictyBase": "DDB_G0284177", "ortholog_type": "O", "panther_family": "PTHR10194", "taxid": 352472, "uniprot_kb": "Q54Q13"}, {"dictyBase": "DDB_G0277675", "ortholog_type": "O", "panther_family": "PTHR10194", "taxid": 352472, "uniprot_kb": "Q86JJ7"}, {"dictyBase": "DDB_G0271750", "ortholog_type": "O", "panther_family": "PTHR10194", "taxid": 352472, "uniprot_kb": "Q55AR6"}, {"dictyBase": "DDB_G0274211", "ortholog_type": "O", "panther_family": "PTHR10194", "taxid": 352472, "uniprot_kb": "Q8SSU4"}, {"dictyBase": "DDB_G0278483", "ortholog_type": "O", "panther_family": "PTHR10194", "taxid": 352472, "uniprot_kb": "Q54Y08"}], "uniprot_kb": "P21359"}, "pathway": {"biocarta": {"id": "hswisnfpathway", "name": "chromatin remodeling by hswi/snf atp-dependent complexes"}, "kegg": [{"id": "hsa04010", "name": "MAPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)"}], "pid": [{"id": "atf2_pathway", "name": "ATF-2 transcription factor network"}, {"id": "hnf3bpathway", "name": "FOXA2 and FOXA3 transcription factor networks"}, {"id": "ras_pathway", "name": "Regulation of Ras family activation"}, {"id": "syndecan_2_pathway", "name": "Syndecan-2-mediated signaling events"}], "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-5658442", "name": "Regulation of RAS by GAPs"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6802953", "name": "RAS signaling downstream of NF1 loss-of-function variants"}, {"id": "R-HSA-6802957", "name": "Oncogenic MAPK signaling"}], "wikipathways": [{"id": "WP2253", "name": "Pilocytic astrocytoma"}, {"id": "WP2261", "name": "Glioblastoma signaling pathways"}, {"id": "WP2586", "name": "Aryl Hydrocarbon Receptor Netpath"}, {"id": "WP3584", "name": "MECP2 and Associated Rett Syndrome"}, {"id": "WP382", "name": "MAPK Signaling Pathway"}, {"id": "WP4223", "name": "Ras signaling"}, {"id": "WP4533", "name": "Transcription co-factors SKI and SKIL protein partners"}, {"id": "WP4539", "name": "Synaptic signaling pathways associated with autism spectrum disorder"}, {"id": "WP4549", "name": "Fragile X Syndrome"}, {"id": "WP4685", "name": "Melanoma"}, {"id": "WP4806", "name": "EGFR Tyrosine Kinase Inhibitor Resistance"}]}, "pdb": ["1NF1", "2D4Q", "2E2X", "3P7Z", "3PEG", "3PG7", "6OB2", "6OB3", "6V65", "6V6F", "7MOC", "7MP5", "7MP6", "7PGP", "7PGQ", "7PGR", "7PGS", "7PGT", "7PGU", "7R03", "7R04", "8E20", "8EDL", "8EDM", "8EDN", "8EDO"], "pfam": ["PF00616", "PF13716"], "pharmgkb": "PA31572", "pharos": {"target_id": 13883, "tdl": "Tbio"}, "pir": ["B55282", "I78852"], "prosite": ["PS50018", "PS50191"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF214670", "relationship": "is"}, {"id": "GNF221152", "relationship": "is"}, {"id": "GNF225598", "relationship": "is"}, {"id": "GNF253211", "relationship": "is"}, {"id": "GNF253212", "relationship": "is"}, {"id": "GNF253213", "relationship": "is"}, {"id": "GNF253214", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF039019", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF086470", "relationship": "is"}, {"id": "GNF086471", "relationship": "is"}, {"id": "GNF086472", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051408", "relationship": "is"}, {"id": "GNF056174", "relationship": "is"}, {"id": "GNF060906", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069909", "relationship": "is"}, {"id": "GNF069910", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF108330", "relationship": "is"}, {"id": "GNF116128", "relationship": "is"}, {"id": "GNF139528", "relationship": "is"}, {"id": "GNF153869", "relationship": "is"}, {"id": "GNF155769", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1", "NG_009018.1", "NW_025791803.1"], "protein": ["NP_000258.1", "NP_001035957.1", "NP_001121619.1"], "rna": ["NM_000267.3", "NM_001042492.3", "NM_001128147.3"], "translation": [{"protein": "NP_000258.1", "rna": "NM_000267.3"}, {"protein": "NP_001121619.1", "rna": "NM_001128147.3"}, {"protein": "NP_001035957.1", "rna": "NM_001042492.3"}]}, "reporter": {"HG-U133_Plus_2": ["204323_x_at", "204325_s_at", "210631_at", "211094_s_at", "211095_at", "211914_x_at", "212676_at", "212678_at", "216115_at", "243476_at"], "HG-U95Av2": ["1236_s_at", "35328_at", "38289_r_at", "739_at", "940_g_at", "961_at"], "HTA-2_0": "TC17000362.hg.1", "HuEx-1_0": ["2576322", "3394260", "3527062", "3527066", "3612825", "3717052", "3717248", "3717250", "3717282", "3800165", "3914700", "3935681"], "HuGene-1_1": ["8006239", "8022424", "8067862"], "HuGene-2_1": "16832920"}, "retired": 646021, "summary": "This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008].", "symbol": "NF1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C0085113"}, "unigene": "Hs.113577", "uniprot": {"Swiss-Prot": "P21359", "TrEMBL": ["K7EID4", "K7ENT2", "J3KSB5", "H0Y465", "A0A8I5KSC3", "J3KRT8", "J3KSX8", "A0A1W2PS74", "A0A8I5KWR6", "A0A8Q3WL11", "A0A1W2PPA7", "A0A8I5KYK6", "A0A8Q3WL04", "J3QSG6", "A0A8I5KWT7", "A0A8Q3WL49", "A0A8I5KSM3", "J3QQN8", "A0A8I5KV71", "K7EJE7", "J3QLS2"]}, "wikipedia": {"url_stub": "Neurofibromin 1"}}